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ABSTRACT 
Calsenilin is calcium (Ca2+) ion Ca2+ binding protein found in the nucleus, plasma 
membrane, and endoplasmic reticulum of neuronal cells.  Calsenilin was first found 
to interact with two proteins involved in early-onset familial Alzheimer disease (AD), 
presenilin 1 and presenilin 2.  Several studies have shown overexpression of 
calsenilin to alter Ca2+ signaling and cell viability in several neuronal cell models of 
AD.  In this study, we show that calsenilin directly interacts with the ryanodine 
receptor (RyR) modulating Ca2+ release from this intracellular Ca2+-activated Ca2+ 
release channel.   
Co-expression, co-localization, and protein-protein interaction of calsenilin and RyR 
in primary neurons and in central nervous system tissue were determined using 
immunoblotting, immunohistochemistry and co-immunoprecipitation.  Mechanisms of 
intracellular Ca2+- signaling controlled by the interaction of calsenilin and RyR, 
including changes in the release of Ca2+ from intracellular stores, were measured 
with single channel electrophysiology and live-cell optical imaging techniques.   
Immunohistochemical studies showed a high degree of co-localization between 
calsenilin and the RyR in neurons of the central nervous system.  Additionally, 
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successful immunoprecipitation of a RyR-calsenilin protein complex from brain 
tissue provided evidence of a functional interaction.  Using electrophysiological and 
Ca2+ imaging techniques the modulatory effects of calsenilin on Ca2+ release in a 
single RyR channel or in a cellular system with a population of RyR channels, 
respectively, whereby RyR-mediated intracellular Ca2+ release by calsenilin was 
determined under physiological and pathophysiological intracellular Ca2+ 
concentrations.   
Calsenilin directly interacts with the RyR, modulating Ca2+ induced Ca2+ release 
(CICR) pathways in neuronal cells.  Further characterization of this interaction and 
its pharmacological and molecular biological control could provide insight into altered 
Ca2+ signaling in neurodegenerative and other diseases controlled by CICR and aid 
in developing novel alternative therapies using these newly identified mechanisms 
as targets.   
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CHAPTER 1 
INTRODUCTION 
 
General overview of Ca2+ signaling: functions, mechanism, and channels 
 
Calcium (Ca2+) is a tightly regulated signaling molecule in cells [11].  
Localized increases in Ca2+ concentration initiate different signaling pathways [11, 
12, 22, 30, 51, 92, 126, 134, 135, 142, 163, 164].  The ability of Ca2+ to initiate 
multiple signaling pathways depends on the source of Ca2+ entry [11].  Ca2+ entry 
into the cytoplasm occurs through multiple ion channels in the plasma and 
endoplasmic/sarcoplasmic reticulum membrane [11]. Ca2+ ion channels possess 
distinct protein ensembles responsible for transmitting Ca2+ signals from the source 
of Ca2+ entry to the site of action [11]. 
For most cell types, the resting intracellular Ca2+ concentration is between 
50nM-150nM [11]. The Ca2+ concentration in the endoplasmic/sarcoplasmic 
reticulum is approximately 100µM, and the Ca2+ concentration outside the cell is in 
the mM range [11].  The high concentration of Ca2+ outside the cell and in the 
endoplasmic/sarcoplasmic reticulum creates a steep concentration gradient between 
cytoplasmic Ca2+, extracellular Ca2+, and endoplasmic/sarcoplasmic Ca2+  [11]. 
Activating Ca2+ ion channels on the plasma membrane rapidly increases Ca2+ 
concentrations in the intracellular loci surrounding the ion channels [12].   The 
increase in Ca2+ concentration surrounding the plasma membrane Ca2+ ion channels 
is amplified by the release of Ca2+ from Ca2+ induced Ca2+ release (CICR) ion 
channels on the endoplasmic/sarcoplasmic reticulum  [12].   The increased Ca2+ 
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concentration surrounding the plasma membrane ion channels creates several 
microdomains of elevated Ca2+ that can reach high µM concentrations. [134].  The 
elevation in Ca2+ concentration in these microdomains along the plasma membrane 
can last from milliseconds to minutes [158].   The microdomains of elevated Ca2+ 
can remain localized, which can result in activation of Ca2+ sensitive proteins, or they 
can move throughout the cell by activating regenerating waves of increased Ca2+ 
throughout the cytoplasm through CICR [134].  Ca2+ signaling is regulated by the 
composition of proteins within close proximity of these elevated Ca2+ microdomains 
[126]. Ca2+ binding proteins, Ca2+ buffering proteins, Ca2+ ATPase pumps, 
exchangers, and Ca2+ ion channels (both plasma and endoplasmic/sarcoplasmic 
reticulum membrane) surrounding the increased Ca2+  microdomains can bind Ca2+ 
[12, 23, 30]. The binding of Ca2+ to Ca2+ binding proteins can initiate signaling 
pathways through the activation, or inactivation, of the Ca2+ binding proteins. The 
binding of Ca2+ to Ca2+ buffering proteins  lowers the amount of free Ca2+ present in 
microdomains of elevated Ca2+, therefore  limiting the spread of increased Ca2+ in 
the cytoplasm.  Ca2+ ATPase pumps, both on the plasma membrane and 
endoplasmic/sarcoplasmic reticulum membrane, rapidly extrude Ca2+ from the 
cytoplasm to subsequently lower the availability of free Ca2+, therefore returning 
intracellular Ca2+ concentration to resting levels [30, 54].  The binding of Ca2+ to 
CICR channels in the endoplasmic/sarcoplasmic reticulum amplifies and propagates 
the initial increase in Ca2+ concentration through plasma membrane Ca2+ ion 
channels [52].  Understanding Ca2+ signaling in cells begins with the activation 
mechanisms of plasma membrane Ca2+ ion channels [59, 126, 156, 171].   
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Plasma membrane Ca2+ ion channels activate in response to extracellular 
stimuli [92]. The mechanism of plasma membrane Ca2+ ion channel activation is 
specific for each family of plasma membrane Ca2+ ion channels [92]. Membrane 
depolarization activates voltage operated Ca2+ channels (VOCC) on the plasma 
membrane [92].   Activation of VOCCs on the plasma membrane generates rapid 
increases in intracellular Ca2+ in excitable cells [104].  The rapid influx of Ca2+ 
through VOCCs on the plasma membrane control muscle contraction and exocytosis 
of neurotransmitters [30].  Receptor operated Ca2+ channels on the plasma 
membrane are activated by binding ligands produced from extracellular signals. N-
Methyl-D-Aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methylisoxazole-4-
propionate acid (AMPA) receptors are activated through binding of the 
neurotransmitter glutamate [142].  Glutamate is released from presynaptic neurons 
into the synaptic cleft where it binds to postsynaptic NMDA and AMPA receptors 
activating them [116]. The influx of Ca2+ through NMDA and AMPA receptors in 
response to glutamate is one mechanism of neuron to neuron communication. 
Another source of Ca2+ entry is through plasma membrane store operated Ca2+ 
channels that refill endoplasmic/sarcoplasmic reticulum Ca2+ stores [116]. The 
transient receptor potential plasma membrane Ca2+ ion channels represents a large 
family of ion channels that are activated in different ways depending on the type of 
channel [115].  Some of the transient receptor potential ion channels are stretch 
sensitive, responding to mechanical disruption of the plasma membrane, while 
others bind agonists for activation [115].  The wide variety of plasma membrane 
Ca2+ channels is the cells first response to extracellular stimuli propagating distinct 
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Ca2+ signals throughout the cell [115].  The amplification of these signals by CICR 
channels in the endoplasmic/sarcoplasmic reticulum increases Ca2+ locally ,or 
transmits these signals throughout the cell[115].  
The major CICR ion channels in the endoplasmic/sarcoplasmic reticulum are 
ryanodine receptors (RyRs) and Inositol-1, 4, 5-trisphophate receptors (IP3Rs) [149]. 
The binding of Ca2+ to intracellular CICR channels, within the microdomains of 
increased Ca2+ concentration, results in activation of these channels and 
subsequent Ca2+ release into the cytoplasm  [11, 12, 30]. The release of Ca2+ from 
intracellular CICR channels can then activate Ca2+ release from adjacent 
intracellular CICR channels [11, 12, 30].  This process of activation allows the influx 
of Ca2+ from the plasma membrane Ca2+  channels to be  amplified by the CICR 
release from RyR- and IP3R- sensitive stores  [134]. The adjacent stimulation of 
clusters of RyRs creates frequent repetitive oscillations of increased Ca2+ [134].  The 
phenomenon of frequent repetitive oscillations of increased Ca2+ has been 
extensively studied in heart tissue [26, 71, 183].  In heart tissue, the coupling of 
RyRs to L-type VOCC regulate excitation contraction coupling [26, 71, 183]. Ca2+ 
influx through L-type VOCCs activate clusters of RyRs that release Ca2+ creating a 
localized increase in Ca2+, or Ca2+ “spark” [26, 71, 183].  The “spark” enlists adjacent 
clusters of RyRs to release Ca2+, creating discrete spatiotemporal increases in Ca2+ 
concentration that coordinate muscle contraction throughout the heart [118]. In 
neurons, NMDA receptor activation in dendrites causes metabatropic glutamate 
receptors to mobilize Inositol 1, 4, 5-trisphosphate (IP3) [94, 150].  IP3 along with 
Ca2+ activate IP3Rs in apical dendrites of neurons initiating a Ca
2+ wave that creates 
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discrete spatiotemporal patterns along dendrites [94, 150].  In dendrites of layer II/III 
and V pyramidal cortical neurons,  the amplification and transmission of Ca2+ along 
apical dendrites has a RyR component as well as an IP3R component [94, 150]. The 
amplification and propagation of Ca2+ signals by RyRs and IP3Rs coordinates the 
activity of adjacent cells. The coordination of signals occurs through the specific 
spatiotemporal pattern of Ca2+ release throughout the cells [94].  In excitable cells, 
Ca2+ plays a pivotal role in induction and transmission of signals within the cell that 
lead to short and long term alterations in protein expression and activity [205].  
These alterations have a profound effect on cell to cell communication, most notably 
in the central nervous system where Ca2+  is involved in every aspect of pre- and 
post- synaptic communication between neurons [10].   
 
The spatiotemporal release of Ca2+ in neurons contributes to neuronal 
plasticity and memory  
 
Ca2+ signaling in neurons involves the integration and communication of 
multiple incoming neuronal messages [138].  Neuronal signaling is processed 
through complex hierarchies of distinct cell populations creating networks of related 
processing units [138].  The organization of neuronal networks is achieved through 
definitive spatial and temporal patterns of increased cytoplasmic Ca2+ [138].  The 
distinct patterns of increased Ca2+ release in neurons regulates transcription [31, 
156], membrane excitability [163], neurotransmitter release [142], apoptosis [111, 
171] , and memory formation [11, 142, 168].   
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Ca2+ signaling directly effects transcription in neurons through Ca2+ binding 
transcriptional modulators such as calsenilin [31], or by initiating Ca2+ dependent 
signaling cascades that effect transcription [208].  The activation of adenylyl cyclase 
by Ca2+ to produce cyclic AMP (cAMP) causes cAMP to directly enter the nucleus 
and effect transcription [208]. Cyclic AMP activation of protein kinase A (PKA) leads 
PKA to phosphorylate target proteins that alter transcription [5].  The activation of 
Ca2+/calmodulin-dependent protein kinase IV (CAMKIV)  can phosphorylate 
Ca2+/cAMP response element binding protein (CREB) altering hippocampal gene 
transcription [19].  Activation of the ras signaling pathway alters long term plasticity, 
and occurs in a Ca2+ dependent fashion  [133].  In CA1 neurons, large Ca2+  signals 
occur at the synapse and cause a Ca2+   wave to travel from apical dendrites to the 
nucleus [21].  This increase in nuclear Ca2+ that originates in dendrites can change 
neuronal plasticity [6].  Plasticity and memory formation occur between pre- and 
post-synaptic neurons through the spatial and temporal aspects of Ca2+ signaling 
[105, 138].  Regulation of membrane excitability in neurons can increase or 
decrease firing patterns between neuronal synapses [3].  A backpropagating action 
potential is a process where an action potential is generated in the soma of neurons 
traveling through the axon, and  through proximal and apical  dendrites [104].  
Studies in dendritic spike timing and back-propagation of signals have shown that  
VOCC location as well as  Ca2+ influx from VOCC’s effects communication in 
hippocampal neurons [55].  The amplification of pre- and post-synaptic signals by 
ryanodine sensitive stores can effect membrane potential therefore altering the 
spatiotemporal firing of neurons [10, 55, 104, 149].  These alterations in firing pattern 
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underlie the major contribution of Ca2+ signal integration during the formation of long 
term potentiation (LTP) and long term depression (LTD) [10, 54, 105].  LTP and LTD 
are processes in neurons, whereby the specific spatiotemporal pattern of 
intracellular Ca2+ can consolidate or erase temporary memories [10, 163].  The 
release of vesicles containing neurotransmitter in pre-synaptic cells are controlled by 
Ca2+ intrusion through VOCCs, and amplification of the Ca2+ signal by internal 
release from ER stores [10, 163].   
 Ca2+ signaling can initiate apoptosis by activating caspases [171]. In 
neurodegenerative disorders, abnormal alterations in Ca2+ homeostasis can 
increase apoptosis through  different mechanisms based on disease and cell type [9, 
11, 83, 109, 111, 165].  The integration of simultaneous neuronal signaling pathways 
can be transmitted by modest alterations in CICR dynamics [50].  RyRs are one of 
the major CICR channels of the ER [13].  RyRs have multiple binding sites for 
modulation of Ca2+ release including signaling molecules, ions, proteins, and other 
ion channels [13]. The different modulatory molecules that bind to RyRs allow 
multiple signaling pathways to be shaped by  Ca2+ release l[13].  
 
Structure, modulation, function, and role of ryanodine receptors in 
neurodegeneration 
 
RyRs are CICR channels consisting of four-approximately 550kDa subunits 
located on the ER [118, 149, 172, 180].  This approximately 2200 kDa channel has a 
large N –terminal cytoplasmic domain [61, 73, 90, 93].  The N-terminal domain acts 
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as a scaffold for multiple modulatory substances that integrate different cellular 
pathways by modulating the release of Ca2+ through CICR   [61, 73, 90, 93].  The 
RyR has three receptor subtypes, RyR1 [198], RyR2 [122], and RyR3 [60] that share 
65%  sequence homology [43, 60, 66, 125].  The two major RyR in the brain are the 
type 2 and type 3 isoforms found in the hippocampus, cortex, and cerebellum [53, 
60, 89, 119, 150].   RyRs have a bell shaped response curve to cytosolic Ca2+, with 
maximum activity between 1-100uM depending on receptor subtype [17].  RyR2 and 
RyR3 are active over a wide range of cytosolic  Ca2+ values, while RyR1 is  activated 
and inhibited at higher cytosolic Ca2+ levels [17, 77, 85, 114, 124, 154].  The 
biophysical modulation of the RyRs can be characterized by a change in the 
frequency of channels openings, the gating time of ON and OFF channel events, 
and the conductance of Ca2+ through the channel [67, 137].  Signaling molecules 
such as ATP [14, 153], cADPR [58, 84],  small molecules such as magnesium [92, 
93] and Ca2+ [17, 77, 85, 154] have an effect on RyR channel function by altering the 
affinity of RyRs for Ca2+.  Phosphorylation of RyRs by protein kinase A (PKA) [29, 
113, 185] and Ca2+/calmodulin-dependent protein kinase II (CaMKII) [186, 189] can 
increase Ca2+-dependent activation of RyRs.  Phosphorylation of RyRs allows 
distinction of different Ca2+ sensitive pathways through phosphorylation of specific 
kinase sensitive domains [132] [186, 191].  The macromolecular complex formed by 
RyRs involves the cytoplasmic N-terminal domain that accounts for 90% of the total 
mass of the receptor [155].  The structural proteins FKBP12 and FKBP 12.6 bind to 
RyRs stabilizing the closed conductance state and coordinating gating between 
adjacent receptor clusters [57, 106, 107, 127].  Homer proteins competitively bind to 
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RyRs and effect channel activity [71, 82].  The long isoform of Homer increases the 
channel conductance of RyRs, while the short isoform of Homer has no effect on 
channel activity [188]. During single channel electrophysiology experiments additive 
increases in the concentration of the short isoform of Homer  dose-dependently 
decreased the heightened activation of RyRs due to the interaction of the long-
isoform of Homer [46, 72, 188].  In cardiac muscle cells, the direct interaction of L-
type Ca2+ channels with RyRs couples the Ca2+ influx through the  plasma 
membrane to CICR [52] [42].  The estrogen receptor beta binds to the RyR 
stimulating single channel activity [136].  Binding of calmodulin (CaM)  to RyRs in 
both the Ca2+ bound and unbound form inhibits the activity of RyR2 at all Ca2+ 
concentrations [148, 174].  The association of RyRs and the N-terminus of the 
Alzheimer’s associated proteins presenilin 1 (PS1) and presenilin 2 (PS2) potentiate 
RyR activity [67, 137].  Alzheimer’s disease mutations in PS1 associated with 
Alzheimer’s disease further increase Ca2+ release [34, 162].  The diversity of 
proteins regulating RyRs including signaling molecules, kinases, other channels, and 
Ca2+ binding proteins shape Ca2+ transients by altering CICR of RyRs [178].  
 
 Structure, expression, and multiple cellular roles of calsenilin 
 
The NCS family of Ca2+ binding proteins contain canonical EF hand Ca2+-
binding domains. The EF hand domain transmits Ca2+ signals through the cell via 
Ca2+-bound activation [23].  The binding of Ca2+ to these molecules can cause 
conformational changes within the proteins themselves, and upon binding the target 
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proteins. These conformational changes induce cellular responses that initiate 
multiple signaling pathways [23].  One such molecule CaM, that is closely related to 
NCS proteins, transmits Ca2+ signals to multiple proteins throughout the cell and 
directly alters CICR through an interaction with RyRs [23, 178].  Another NCS 
protein, calsenilin, has been shown to alter the dynamics of Ca2+ signaling [98, 100] 
through a yet unidentified protein interaction.   
Calsenilin/KChIP3/DREAM (hereafter called calsenilin) is a 31kD protein that 
is part of the (NCS) family [23]. Calsenilin contains a C-terminus with 4 EF-hand 
motifs -reminiscent of the frequenin NCS-1 subfamily, however calsenilin has a 
unique amino terminus [24].  Calsenilin binds to Ca2+ with high affinity at EF hands 3 
and 4, magnesium at physiological concentrations at EF-hand 2, and contains a 
CPXG sequence on the first EF-hand that prevents Ca2+ binding [41, 120, 193].  
Ca2+ binding to the EF hands of calsenilin cause the formation of homodimers and 
homotetramers that translate Ca2+ dependent activity to target molecules [41, 103, 
120, 121].  Calsenilin is found in human brain extracts [25], and in all mouse nervous 
tissue with particularly high expression levels in the hippocampal layers (dentate 
gyrus, CA1-3), layers V & VI in the cerebral cortex, granule layers of the cerebellum, 
and olfactory centers [44, 62, 157, 159, 190, 192, 194].  Calsenilin is expressed 
throughout mouse development with the highest expression levels in adults [194].   
 Calsenilin was first identified to interact with the C-termini of Alzheimer’s 
disease related proteins PS1 and PS2. This interaction regulates the level of a 
20kDa specific caspase cleavage product of PS2 [24].  Calsenilin itself is a substrate 
for caspase 3 cleavage [37] which is regulated by phosphorylation of Ser63 in 
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calsenilin [36].  In neuroglioma cells, calsenilin preferentially interacts with the 20kDa 
PS2 C-terminal fragment which is increased in AD and associated with PS2 Familial 
Alzheimer’s Disease (FAD) associated mutations in this protein [37].  Though not 
directly a part of the γ-secretase complex [48], calsenilin affects the γ-secretase 
cleavage of N-cadherin [74] and increases the γ-secretase production of Aβ [79].  In 
calsenilin knockout mice the levels of Aβ as well as Aβ induced apoptosis is 
decreased [99].  The pro-apoptotic function of calsenilin, which is associated with 
increased cytosolic Ca2+ concentration [80], is coordinated with presenilin/ γ-
secretase activity and enhanced in the presence of PS1 gain of function AD mutants 
[78].In neuroglioma cells overexpression of calsenilin, enhances apoptosis in 
response to serum withdrawal and thapsigargin treatment is [100].  This 
enhancement in apoptosis is thought to occur through altered Ca2+ release and 
correlates with increased caspase activity [100].  Calsenilin can alter IP3R mediated 
Ca2+ signaling and Ca2+ stores in the ER, which directly effects Ca2+ levels within the 
cell [49, 98].   
 Calsenilin regulates the expression of the human prodynorphin gene in a Ca2+ 
dependent manner [31].  Prodynorphin is distributed throughout the CNS and 
involved in pain and memory acquisition [146].  Calsenilin regulates prodynorphin 
through an interaction with the downstream regulatory element (DRE) hence the 
name DRE-antagonist regulator (DREAM) [31].  Calsenilin, in the absence of Ca2+, is 
bound to the DRE site silencing prodynorphin gene expression. Upon Ca2+, and c-
AMP elevation, calsenilin binding to the DRE site is abolished [31, 41, 103, 121].  
Prodynorphin expression alters several signaling pathways due to the fact it is a 
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precursor for several opioid receptor agonists.  Opioid receptor activation can 
influence phosphorylation and Ca2+  concentrations within the cell [146].  In 
hematopoietic cells, calsenilin binding to a DRE site in the 3’ untranslated region of 
the pro-apoptotic HRK gene represses HRK expression [140].  Elevation in Ca2+, PI-
3 kinase phosphorylation of calsenilin, and apoptotic inducers all reduce calsenilin 
binding to the DRE site increasing apoptosis [139, 140].  In cerebellar neurons 
calsenilin binding to a DRE site in the sodium Ca2+ exchanger (NCX3) gene 
decreases NCX3 expression levels in the cell [56].  This decrease in NCX3 causes 
increased susceptibility to Ca2+ induced apoptosis [56].  Furthermore, in PC12 cells, 
calsenilin binding to peroxiredoxin, an antioxidant enzyme that functions as a redox 
sensor, enhances calsenilin binding to DRE sites [130].  Knockdown of calsenilin in 
PC12 cells increases oxidative stress induced damage [130].  The transcription of 
glial fibrillary acidic protein (GFAP), an astrocyte expressed stress marker, is 
controlled through a calsenilin interaction in the promoter region [32, 177].  This 
interaction is regulated through a pituitary adenylate cyclase-activating polypeptide–
cAMP-Ca2+-calsenilin interaction [32, 177].  This occurs in Mueller glial cells in the 
retina in a NMDA - cAMP response element binding protein (CREB) phosphorylation 
dependent manner [35, 91, 129].  Binding of calsenilin to phosphorylated CREB 
decreases the interaction with DRE sites, and regulates the production of the early 
response gene c-fos in a cAMP dependent manner [28, 47, 95, 96].  In spinal 
inflammation the production of brain derived neurotrophic factor is controlled by 
calsenilin [131, 196], and in kainite and pentylenetetrazol  induced seizure the levels 
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of calsenilin in dentate gyrus, cerebral cortex, and piriform complex are altered 
providing evidence for calsenilin in inflammatory responses [70, 108].   
 Calsenilin directly interacts with rapidly inactivating voltage gated potassium 
channel (Kv4.2) potassium channels on the plasma membrane. The interaction with 
Kv4.2 channels occurs in the α pore forming subunit altering the biophysical release 
properties of the channel [182].  The interaction of calsenilin with Kv4.2 channels 
stabilizes tetramerization of the four Kv4.2 subunits [7, 27, 75, 117, 181].  This 
interaction occurs in a 1:1 ratio between each Kv4.2  subunit and calsenilin. This 
interaction includes DPP 10, a cell adhesion related protein, that form a multiprotein 
complex regulating channel activity [7, 27, 75, 117, 181].  Calsenilin aides in the 
tetrameric assembly of Kv4.2 channels, and rescues zinc mutants that do not form 
tetramers and remain in the ER/Golgi [87]. Co-expression of Kv4.2 and calsenilin in 
Chinese hamster ovary (CHO) cells alters Kv4.2 activity by increasing peak current, 
peak current density, inactivation time constant, and recovery from inactivation [2].  
The increase in channel density can be attributed to calsenilin to trafficking Kv4.2 
channels from the ER to the plasma membrane [151].  Kv4.2 channels are found at 
high density in proximal and distal dendrites [18].  The modification of Kv4.2 channel 
activity by calsenilin returns resting dendritic membrane potentials faster, eliminating 
back propagation of action potentials from the soma [18]. In the presence of a 
constitutively active form of Ca2+-calmodulin-dependent kinase II (CaMKII) and 
calsenilin, Kv4.2 current amplitudes and surface expression were increased linking 
Kv4.2 channel activity to calsenilin and Ca
2+ [179].  Alterations in the inactivation time 
constant of Kv4.2 channels are transmitted to Kv4.2 by arachidonic acid and PKA 
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phosphorylation only in the presence of calsenilin [69, 143].  Signaling between T-
type Ca2+ channels (Cav3) and Kv4.2 channels through a calsenilin interaction is 
thought to link Ca2+ signaling and Kv4.2 channels [3].  Finally, calsenilin binds to the 
C0 domain of the NR1 subunit of NMDA receptors causing an inhibition of NMDA 
receptor currents and reduction of NMDA receptor activated Ca2+ currents [197].   
 Calsenilin has a myriad of functions that alter Ca2+ signaling and cell viability 
in neurons [31].  Calsenilin affects Ca2+ levels in cells, excitability in neurons, 
transcription, and cleavage products AD related-proteins.  The similar roles of 
calsenilin and CICR channels in the maintenance of physiological Ca2+ and the 
perturbation of Ca2+  in pathological states is striking.   
 
Perturbations of Ca2+ homeostasis in Alzheimer’s disease 
 
 Subtle changes Ca2+ homeostasis can affect cell viability, transcriptional 
regulation of apoptotic proteins, and neuronal connectivity [9].  In the progression of 
AD all of these processes are altered [9]. There is also an increase in the production 
of Aβ plaques and tau neurofibrillary tangles [9].  The linking of FAD with sporadic 
Alzheimer’s disease (SAD) could provide clues into the etiology and progression of 
nongenetic SAD.   
AD is a neurodegenerative disorder that is clinically characterized by a loss of 
higher cognitive function and memory with marked behavioral abnormalities [63].  
Pathologically, AD is characterized by the presence of β amyloid (Aβ) plaques, 
neurofibrillary tangles, and progressive neuronal loss [63].  One type of AD which 
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accounts for approximately 5% of AD cases is early onset familial AD (FAD) [63].  
FAD occurs in people before 65 years of age and is correlated with missense 
mutations in the amyloid precursor protein (APP), γ-secretase proteins, PS1 and 
PS2 [63].  The second type of AD, which accounts for the remainder of the cases, is 
sporadic AD (SAD) [63].  SAD occurs later in life, usually after 65 years of age, and 
has genetic and non-genetic factors [63].  Typical disease etiology of SAD includes a 
slow decline in cognition and memory, and increase in cell loss in the hippocampus 
and cortex [63].  Alterations in Ca2+ signaling occur before these changes become 
evident [16], suggesting that Ca2+ dysregulation plays a role in the pathogenesis of 
AD.  The Ca2+ hypothesis of AD states that a remodeling of Ca2+ homeostasis in 
response to altered β-amyloid accumulation is an underlying cause of memory loss 
and cell death associated with AD [9, 109, 165].  Increased β-amyloid accumulation, 
as well as normal aging, can cause an increase in the resting Ca2+ concentration 
within neurons [86, 102, 173].  This alteration in normal Ca2+ concentration induces 
oxidative stress [88, 110], increases cell death from excitotoxicity [4], and effects 
learning and memory (reviewed [9]).  Cortical neurons from triple AD mutant 
transgenic mice show increased resting Ca2+ levels [102].  Neocortical neurons from 
triple AD mutant transgenic mice also show elevations in resting Ca2+ levels in 
dendrites and spines as a function of proximity to Aβ deposits [86].  In young and 
aged transgenic mouse models of AD there is a correlation between increased Aβ 
and aberrant expression and release of RyR sensitive Ca2+ stores [83, 166].  
Mutations in PS1 and PS2 increase recruitment, expression, and Ca2+ release from 
RyRs in transgenic mouse models of AD in cortical, and hippocampal neurons [33, 
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34, 97, 152, 161].  The increase in Ca2+ content and Ca2+ release from ER mediated 
stores causes an increase in apoptosis in several models of AD [51, 97, 161].  
These alterations in intracellular Ca2+ signaling suggest that abnormal activities of 
RyRs may play a part in the progression of AD.  Modulation of RyRs by AD related 
proteins such as PS1, PS2 and calsenilin could help dissect the role of RyRs in AD, 
and provide possible targets for the modulation of intracellular Ca2+ release.   
 
Identification of a direct protein-protein interaction between calsenilin and 
neuronal RyRs as a potential mechanism for the alteration of CICR 
 
 The goal of the present study is to identify a direct interaction of calsenilin 
with neuronal RyRs describing a mechanism of action for the underlying modulation 
of CICR. By identifying an interaction and describing the modulatory effect we will 
describe whether this interaction alters intracellular Ca2+ levels in physiological and 
pathophysiological states.  Calsenilin and neuronal RyRs directly interact with the 
AD related proteins PS1 and PS2 to alter the Ca2+ levels within the cell in normal 
physiological cell signaling [24, 49, 67, 81, 98, 100, 137].  In several models of AD, 
the interaction between calsenilin and PS1 and PS2, as well as RyRs and PS1 and 
PS2, cause increased apoptosis, abnormal Ca2+ signaling, and vulnerability to 
various cellular insults  [33, 78-80, 83, 99, 100, 152, 161, 166].  The ability of NCS to 
modulate RyRs and alter CICR suggests a possible role for calsenilin and RyRs in 
shaping neuronal cell signaling [155]. The fact that calsenilin binds with PS1 and 
PS2 in the ER  [172], and multiple targets of several Ca2+ signaling  pathways [31, 
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79, 96, 100, 195] including modulation and tetramerization of plasma membrane 
Kv4.2 channel that is directly linked to T-type Ca
2+ channels [2, 3, 75], suggests a 
possible interaction between calsenilin and RyRs.  To date, the link between altered 
Ca2+ release and calsenilin has not been studied in depth and is widely seen as a 
consequence of alterations in transcription, Kv4.2 channel action, and γ-secretase 
activity.  
 
Targets for the modulation of Ca2+  have proved effective in slowing the 
progression of neuronal loss in several neurodegenerative diseases [45], but this 
approach is applied to whole receptor populations in the body affecting countless 
signaling pathways.  Targeting a modulatory protein rather than a whole ion channel 
population would allow for tunable manipulations of specific cells populations.  For 
the current study, we hypothesize that calsenilin and RyRs directly interact to 
modulate RyR Ca2+ release.  To test this hypothesis we used immunological, 
electrophysiological and live imaging techniques in neuronal cells and tissue to 1) 
determine whether there is colocalization of RyR and calsenilin, 2) to determine 
whether a direct protein-protein interaction of RyR and calsenilin exists, 3) to test the 
effect calsenilin has on single RyR channels, and 4) to test the effect calsenilin has 
on a population of RyR channels, in vitro. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
 In order to verify that calsenilin and neuronal RyRs interact, the expression 
pattern of these two proteins was assessed in neuronal cells and whole brain tissue 
sections using fluorescent immunohistochemistry.  The quantification of co-
localization was calculated using standard algorithmic formulas, Pearson’s and 
Mander’s coefficients.  Once co-localization was established, testing for direct 
protein-protein interactions was verified using co-immunoprecipitation studies 
reported with Western blot analysis.  The alterations in biophysical Ca2+ release from 
single brain RyRs in the presence of calsenilin were measured using planar lipid 
electrophysiology.  The changes in single channel RyRs biophysical release was 
assessed utilizing a whole cell paradigm using overexpression of calsenilin in order 
to determine how the changes in single channel RyR Ca2+ release translated into 
whole cell Ca2+ release signals.   
 
Growth and preparation of the SH-SY5Y neuroblastoma cell line: an 
experimental neuronal cell model for Ca2+ release studies  
 
SH-SY5Y neuroblastoma cells (ATCC, Manassas, VA) were thawed from 
cryo-storage (-80°C), and grown in a T-150 cell culture flask (TPP, MidSci, St.  
Louis, MO) using SH-SY5Y media (10% fetal bovine serum (PAA, Piscataway, NJ), 
1:200 penicillin/streptomycin, 50% Ham’s F-12 media, 50% eagle minimum essential 
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media (Lonza, Walkersville, MD)) where cells were maintained in a maintained in a 
37ºC, 5%CO2, 95% O2 incubator.  Once 50%-70% confluency was reached, media 
was removed and placed into a 50mL conical Falcon tube where 5mL of Trypsin-
EDTA (Mediatech, Manassas, VA) was added to the flask and allowed to incubate a 
37oC for 2-5 minutes.  Following incubation, 5mL of the removed media was placed 
back into the flask to inhibit the trypsin digestion.  The flask was washed three times 
with the removed media and placed into the 50mL Falcon tube.  The sample was 
spun at 200xg for 3 minutes and the supernatant was removed.  The pellet was 
resuspended in 1 mL of cell media and 20 µL of the suspension was counted using a 
Cellometer Auto T4 (Nexcelom Bioscience, Lawrence, MA).  The cells were plated at 
25,000 cells per laminin/poly-d lysine coverslips (BD Biocoat, Bedford, MA) and 
maintained in a 37ºC, 5%CO2, 95% O2 incubator.   
 
Growth and preparation of rat cortical neurons: an in vitro model to establish 
endogenously expressed calsenilin and RyRs 
 
NeuroPure™ embryonic day 18 (E18) Sprague Dawley rat cortical cells 
(Genlantis, San Diego, CA) were prepared following the according to manufacturer’s 
protocol.  The shipping media from the vial containing the E18 rat brain tissue was 
removed and replaced with 5mg of NeuroPapain™ enzyme dissolved in 
NeuroPrep™ medium (Genlantis), and incubated for 15 minutes at 37oC (to 
breakdown the extracellular matrix).  The tissue was then centrifuged at 200xg for 1 
min and supernatant removed and discarded, and replaced with the original shipping 
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media.  The tissue was resuspended with a fire polished glass pipette by triturating 
approximately 15 times in (Genlantis).  Subsequently, the cells were centrifuged at 
200xg for 1 minute and resuspended in NeuroPure™ plating medium (Genlantis).  In 
order to determine the cell density, the cell suspension was mixed with a trypan blue 
at a 1:1 ratio, and counted using a Cellometer Auto T4 (Nexcelom Bioscience).  The 
cells were plated at 25,000 cells per laminin/poly-d lysine coverslips (BD Biocoat) 
and maintained in a 37ºC, 5%CO2, 95% O2 incubator.   
 
Immunocytochemistry: to establish the expression pattern and co-localization 
of calsenilin and RyRs in neuronal cell models 
 
SH-SY5Y cells or primary cortical neurons were allowed 1 or 7 days, 
respectively, to adhere to laminin/poly-d lysine coverslips (BD Biocoat), then were 
washed three times in phosphate buffered saline (PBS) (Lonza), and fixed for 15 min 
in 4% paraformaldehyde (PFA) (4% PFA w/v, 0.1M NaOH, 0.1M NaH2PO4, pH 7.3 
(Sigma-Aldrich)) to preserve cellular structures by methylene crosslinking.  Following 
the removal of PFA, three 10 min washes with PBS were performed.  In order to 
block nonspecific secondary antibody binding, a serum buffer from the secondary 
antibody host species was applied (donkey serum blocking buffer (1% BSA fraction 
V (EMD Millipore, Gibbstown, NJ), 0.5% Triton x -100 (Sigma-Aldrich), 10% donkey 
serum (PAA) in PBS at pH of 7.4)), where cells were incubated for 1 hour at room 
temperature.  The block was removed and the cells were incubated with goat anti-
calsenilin monoclonal antibody raised against the full length human calsenilin (1:50; 
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Santa Cruz Biotechnologies, Dallas, TX) and rabbit RyR2 antibody raised against a 
synthetic peptide variant from the transmembrane region of human RyR2 (1:10000, 
Chemicon Biotechnologies, Temecula, CA) or a rabbit ryanodine type 3 receptor 
raised against a synthetic peptide variant from the transmembrane region of human 
RyR3 (1:5000; Chemicon Biotechnologies)  diluted in incubation buffer (1% BSA 
fraction V, 0.  5% Triton x-100, 3% donkey serum in PBS at a pH of 7.4) and 
incubated for 36-48 hours at 4°C.  The primary antibody was removed, and the cells 
were washed three times in PBS.  Cells were incubated for 1 hour in the dark at 
room temperature with AlexaFluor 488 donkey anti-goat secondary antibody 
(1:2000; Life Technologies, Carlsbad, CA; the calsenilin primary antibody was raised 
in goat and therefore anti-goat secondary antibody will bind specifically to the 
primary antibody) and AlexaFluor 594 donkey anti-rabbit (1:2000; Life Technologies; 
used for both of the RyR antibodies because the species specific label of the primary 
antibody).  AlexaFluor 488 fluorescent antibody has a peak excitation wavelength of 
490nm- 495nm and AlexaFluor 594 fluorescent antibody has a peak excitation 
wavelength of 590nm. The non-overlapping excitation and emission spectra of the 
two secondary antibodies used allows acquisition of both signals without the use of 
complex spectral unmixing software.    Following secondary antibody incubation, the 
cells were washed in PBS with 1:10000 4', 6-diamidino-2-phenylindole (DAPI) (which 
binds strongly to A-T regions in DNA) for three minutes.  The cells underwent three 
subsequent 10 minute washes in PBS, followed by one 10 min wash in deionized 
water (to remove excess phosphate), and the coverslips were mounted to 
microscope slides with Aqua-Polymount (Polysciences, Warrington, PA).   
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Collection and preparation of mouse brain sections: to establish 
endogenously expressed calsenilin and RyRs in the intact mouse brain 
 
C57BL/6 mice (Jackson Laboratories, Bar Harbor, MA) were used in this 
study as a model for human brain physiology.  Mice were euthanized using IACUC 
approved methods of carbon dioxide overdose.  The heads of the mice were 
removed from the body by a lateral incision above the C4 cervical segment but 
below the brain stem.  After removal of the skull from the body, the fur and skin over 
the crown of the skull was removed, and an incision through the medial line of 
cranium was made from the most posterior to the most anterior portion.  Further 
incisions were made in the posterior and anterior portions of the skull perpendicular 
to the medial incision.  The crown of the skull was then removed allowing access to 
the brain.  The brains were removed from the cranial cavity using a spatula, and 
immersion fixed in 4% PFA overnight.  Following the removal of PFA, the brain was 
rinsed in PBS.  The tissue was then sequentially cryoprotected in a graded series of 
10% sucrose, then 20% sucrose, then 30% sucrose, in order to ensure the 
preservation of cellular structures within the tissue.  Each cryoprotection step was 
done at 4oC overnight.  Tissue was then removed from the final sucrose solution and 
placed in a mold, where the tissue was incubated in Tissue-Tek Optimal Cutting 
Temperature (OCT) Embedding Medium (Tissue Tek, Torrance CA) for 1hr at 4oC.  
The samples were then placed in -80oC isopentane (Alfa Aesar, Ward Hill, MA) to 
solidify the OCT compound and snap-freeze the tissue.  Molds were sectioned at 
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30µm using a Leica model CM 3050S Cryostat.  Sections were placed in PBS and 
stored at 4oC until immunohistochemistry was performed.   
 
Immunohistochemistry: in order to establish the expression pattern and co-
localization of calsenilin and RyRs in intact mouse brain tissue 
 
The sectioned tissue was placed in 1mg/ml sodium borohydride (Sigma 
Aldrich) 3 times for 10 minutes to reduce reversible Schiff’s bases that may have 
formed during PFA-fixation [8].  In order to eliminate nonspecific binding, blocking 
buffer using serum from the same host species of the secondary antibody was 
applied (donkey serum blocking buffer (1% BSA fraction V (EMD Millipore), 0.5% 
Triton x -100 (Sigma-Aldrich), 10% donkey serum (PAA) in PBS at pH of 7.4)), 
where brain sections were incubated for 1 hour at room temperature.  The block was 
removed and the cells were incubated with goat anti-calsenilin monoclonal antibody 
raised against the full length human calsenilin protein (1:50; Santa Cruz 
Biotechnologies) and rabbit RyR2 antibody raised against a synthetic peptide variant 
from the transmembrane region of human RyR2 (1:10000, Chemicon 
Biotechnologies) or a rabbit RyR3  raised against a synthetic peptide variant from 
the transmembrane region of human RyR3 (1:5000; Chemicon Biotechnologies)  
diluted in incubation buffer (1% BSA fraction V, 0.  5% Triton x-100, 3% donkey 
serum in PBS at a pH of 7.4) and incubated for 36-48 hours at 4°C.  The primary 
antibody was removed, and the brain sections were washed three times in PBS.  
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Brain sections were incubated for 1 hour in the dark at room temperature with 
AlexaFluor 488 donkey anti-goat secondary antibody (1:2000; Life Technologies; 
used to label the calsenilin primary antibody) and AlexaFluor 594 donkey anti-rabbit 
(1:2000; Life Technologies; used for both of the RyR antibodies).  AlexaFluor 488 
fluorescent antibody has a peak excitation wavelength of 490nm-495nm and 
AlexaFluor 594 fluorescent antibody has a peak excitation wavelength of 590nm. 
The non-overlapping excitation and emission spectra of the two secondary 
antibodies used allows acquisition of both signals without the use of complex 
spectral unmixing software.  Following secondary antibody incubation, the brain 
sections were washed in PBS with 1:10000 4', 6-diamidino-2-phenylindole (DAPI) 
(which binds strongly to A-T regions in DNA) for three minutes.  The brain sections 
underwent three subsequent 10 minute washes in PBS, followed by one 10 min 
wash in deionized water (to remove excess phosphate).  The brain sections were 
then incubated in 25mM CuSO4 for 10 minutes in order to mask the fluorescent 
pigment lipofuscin, which are pigment granules that accumulate in the cytoplasm of 
cell in the central nervous system.  The sections were subsequently washed three 
times with PBS for 10 minutes, followed by a 10 min wash in deionized water (to 
remove excess phosphate), where coverslips were mounted to microscope slides 
with Aqua-Polymount and allowed to dry overnight.   
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Confocal microscopy: imaging of calsenilin and RyR immunoreactivity in 
neuronal cells and tissue 
 
Confocal imaging settings for accurate data acquisition 
Images were acquired using a Leica laser-scanning TCS SP5X confocal 
microscope with tunable pulsed White Light Laser, at 63x oil objective.  Collection 
and visualization of images were done with Leica Acquisition Software.  All cell 
images were acquired with the following settings: 95.5 µm pinhole, xyz scan mode, 
107.0 µm width and height, 1.6 µm depth with step sizes of 0.13 µm, voxel width and 
height 52.3 nm and depth at 125.9 nm, 2048 by 2048 pixels with a 4x line average 
and 2.3 zoom.  Laser power, offset and gain remained constant throughout all cells 
imaged.  All brain images were acquired with the following settings: 102.8 pinhole, 
xyz scan mode, 8 bit resolution, 60.0 µm width and height, 1.0 µm depth with a step 
size of 0.13 µm, voxel width and height 58.7 nm and depth at 125.9nm, 1024 by 
1024 pixels with a zoom of 4.1.  Laser power, offset and gain remained constant 
throughout all experiments.  AlexaFluor 488 was excited at a wavelength of 495nm 
and emission was collected at 496nm-647nm.  AlexaFluor 594 was excited at a 
wavelength of 590nm and collected at 602-760nm.  The collection of each of the 
fluorophores was done sequentially to avoid crosstalk, which is the excitation of one 
fluorophore causing a spillover emission signal of the other fluorophore.  Due to the 
excitation of AlexaFluor 594 being 590nm, which is in the emission spectra of 
AlexaFluor 488, AlexaFluor 488 was always excited first, then AlexaFluor 594, and 
lastly DAPI.   
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Acquisition theory to ensure maximum resolution and contrast sensitivity of 
confocal image acquisition settings 
The optimizing of imaging parameters allows a precise definition of the 
sampling frequency used by a particular microscope. By calculating the correct 
sampling frequency for the microscopes hardware any sample can be accurately 
visualized. By defining the sampling frequency, we avoid false positives that occur 
from under sampling, and avoid superfluous collection of data due to oversampling.  
All imaging was done in such a way as to maximize the resolution and contrast 
sensitivity of the microscope. In order to identify the maximum resolution of each 
objective used an Airy disk calculation was done.  The Airy disk is a calculation of 
the diffraction pattern of light, and can be visualized as a sine curve of the maximum 
and minimum intensity of the signal.  The Airy Disk is calculated for each objective 
separately, using the formula r=0.61 λ/NA (where λ is the emission wavelength of 
the secondary antibody and NA is the numerical aperture of the objective). The 
numerical aperture for each objective takes into account the half angle of the cone of 
light that enters the lens, and the refraction index for the medium used (i.e. Oil=1.56, 
water=1.33, air=1). The Airy disk calculation quantifies the distance with which the 
objective used can resolve a single point of light. To maximize spatial resolution, or 
contrast, of two points the Rayleigh criterion was applied.  The Rayleigh criterion 
states that the maximum spatial resolution that can be expected in an image (the 
minimum distance that can accurately determine the separation of two objects in 
close proximity) is achieved by the lining up of the zero point of one Airy disk with 
the maximum point of the next objects Airy disk.  This criterion becomes applicable 
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when the sampling frequency used to collect the image is to be determined. In 
microscopy the sampling frequency is the pixel size. Utilizing the Nyquist theorem, 
which states that to accurately reproduce a sine curve sampling, must be done at 
2.3 times the frequency, the optimum pixel size as related to the maximum 
resolution, or Airy disk, can be chosen.  To maximize the spatial resolution that can 
be expected from two objects that are in close proximity as defined by the Rayleigh 
criterion, the application of the Nyquist theorem to the half curve of the Airy disk will 
ensure accurate reproduction of the areas of the curve that derive maximum 
contrast.  These parameters were applied to the collection of all confocal images in 
all imaging experiments [20, 147].   
 
Co-localization software was used to analyze and discriminate between the 
true immunoreactivity signal over background signal 
Fiji ImageJ was used to quantify co-localization between calsenilin and the 
RyR utilizing the ‘Intensity Correlation Analysis’ plugin.  The output of this analysis 
program was a Pearson’s coefficient (Rr) and the Mander’s coefficients (M1, M2) for 
each protein.  To ensure that the co-localization output was true and not due to a 
random overlap of pixels, the Costes method was applied to the images.  To ensure 
signal accuracy, several control staining/collections were done to set a fluorescent 
threshold level.  The threshold level is a value that describes fluorescence that is 
due to nonspecific signals.  Only values above these levels were considered true 
signals.  Nonspecific values are tissue/cell autoflourescence (no antibodies, inherent 
fluorescents of tissue/cells), nonspecific secondary fluorescence (due to the 
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secondary antibody binding to tissue/cell), crosstalk (e.g. fluorescent signals 
collected in 602-760nm from 495 excitation (AlexaFluor 488 excitation in AlexaFluor 
594 emission)), and background fluorescence.   
 
Pearson’s coefficient: to measure the linear relationship of calsenilin and RyR 
immunoreactivity 
The Pearson’s coefficient is an algorithm that measures the covariance of two 
fluorophores within the analyzed image. The covariance is described as a linear 
relationship between the signals in the two channels. The values are from -1 to 1 
with a value of -1 describing an inverse relationship between signals (as one signal 
increases the other decreases) and defined as no colocalization. A value of 1 
describes a relationship in which the two channels are perfectly colocalized (as one 
signal increases the other increases), and a value of 0 is defined as a nonlinear 
relationship between the two species.  The Pearson’s coefficient is not affected by 
background, but can be affected by noise. This limitation can be overcome by 
applying a threshold during analysis, and correctly setting the gain and offset 
function during image acquisition. The Pearson’s coefficient allows the correlation of 
how two signals interact but does not take into account the contribution of each of 
the fluorophores separately as the Mander’s coefficient does.  
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Mander’s overlap coefficient:  a measurement of the overlap of calsenilin and 
RyR immunoreactivity 
The Mander’s coefficient is an algorithm that measures the proportion of 
overlap of each channel with the other [38].  The values of the Mander’s coefficient 
are between 0 to 1, with a value of 0 describing no co-localization and a value of 1 
describing perfect co-localization.  The Mander’s coefficient allows us to establish 
the percentage of each protein that is co-localized with each other.  A value of 1 
means that the two proteins of interest are localized together 100% of the time, while 
a value of 0 means that the two proteins are never localized together.  For most 
proteins with multiple binding partners and activities in the cell, we would expect a 
value between 0.3 - 0.7, indicating the proteins are sometimes localized together, 
but also to have other proteins they associate with.  The Mander’s coefficient is not 
influenced by the intensity of the two signals, but is sensitive to high background.  
This limitation can be overcome by applying a threshold during analysis, and 
correctly setting the gain and offset function during image acquisition.  The Mander’s 
coefficient allows us to quantify the percentage of each species that is expressed 
within a certain image.   
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Costes method: to determine if the co-localization established between 
calsenilin and RyRs was due to random chance.   
The Costes method is an approach to test the validity of the co-localization 
values with respect to the co-localization values that would be calculated by random 
overlap [40].  This method allows us to verify whether proteins are contained within 
the same area, or if they are randomly associated due to a captured event during 
fixation, the random association of background signal to real signal, and 
happenstance detritus on coverslips.  In this method, one of the channels pixels are 
scattered randomly and the Pearson’s value derived from this overlap is compared 
to the co-localization value derived from the true sample.  The values are compared 
and the significance of the true co-localization is indicated by a P-value of > 95%.  In 
this study 200 randomization patterns were compared to the value from the true 
localization.   
 
Co-immunoprecipitation: to determine a direct protein-protein interaction 
between calsenilin and RyRs 
 
Protein-A (Staphylococcus aureus) coated magnetic beads (EMD Millipore) were 
coated with antibodies used for co-Immunoprecipitation experiments.  Protein A 
magnetic beads were used due to their high affinity for the rabbit IgG2 of the 
precipitating antibody rabbit anti-RyR2 antibody (Millipore, MA, USA, raised against 
the synthetic peptide from the variant TM region of human RyR2).  ER microsomes 
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(250µg; method detailed later in the chapter) alone or with rabbit anti-RyR antibody 
(1:200; #AB9080; Millipore) or control rabbit IgG (2mg/ml magnetic beads), with or 
without recombinant calsenilin protein (20nM, 40nM, 60nM, 80nM and 100nM; Mus 
musculus; transcript variant 1, mRNA; accession number, NM_019789; protein was 
obtained and purified by Brian Gerdes in the Vision Research Center), and were 
incubated under constant shaking at 4oC for 12hrs.  The recombinant calsenilin 
protein carries a glutathione S-transferase (GST) tag, therefore instead of detection 
of calsenilin protein its actual weight of approximately 29-30kDa, the protein is 
detected at the combined calsenilin and GST molecular weight of between 51-55kDa 
(see Figure 1).  Following incubation, the slurry of antibodies and proteins were 
incubated at room temperature with protein A magnetic beads (50ul) for 10 minutes, 
washed 3 times in PBS with 0.1% Tween 20, and eluted with Western Blot Sample 
Buffer sodium dodecyl sulfate (SDS): 10%, glycerol: 10%, β-mercaptoethanol: 1%, 
bromophenol blue: 0.004%, tris (hydroxymethyl) aminomethane (Tris)-HCl: 0.5 M, 
pH 6.8) and heated for 10 min at 80oC.  Samples were then probed using the 
western blot technique.   
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Figure 1. Immunoblot of calsenilin recombinant protein with a GST tag, detected at 
approximately 51 kDa. 
Immunoblot image of calsenilin protein with a GST tag probed with mouse 
monoclonal calsenilin antibody (1:500; clone 40A5; #05-756; Upstate, NY, USA) 
overnight at 4°C with an horseradish peroxidase (HRP) linked anti-mouse 
secondary antibody (1:5000; #31430; Thermo Scientific, Glen Burnie, MD, 
USA), and imaged on the Syngene G:BOX using Syngene GeneSnap 
acquisition software 
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Western blotting: to detect the protein-protein interactions following co-
immunoprecipitation  
 
Samples prepared from co-immunoprecipitation were loaded on a 3-8% NuPAGE® 
Novex® Midi Tris-acetate gel (Life Technologies) for electrophoresis in tris-acetate 
buffer (Life Technologies).  Protein size was determined using Spectra Multicolor 
High Range Protein Ladder (Fermentas, Glen Burnie, MD).  Proteins were separated 
at 100V, 50-60mA for 1.5-2hrs and then transferred to Amersham Hybond-ECL 
blotting paper (0.45µm, GE Healthcare) in transfer buffer (25mM Tris-Base, 192mM 
Glycine, 20% methanol, 0.01% SDS (Sigma)) at 50V/250-300mA for 2hrs at 4°C.  
Membranes were blocked for 1 hour at room temperature in blocking buffer (5% 
BSA, 0.2% Tween 20 (Sigma) in tris buffer saline (TBS, Blots were then incubated 
for 12-16hrs in washing buffer (0.2% Tween 20 in TBS) with mouse monoclonal 
calsenilin antibody (1:500; clone 40A5; #05-756; Upstate, NY, USA) and mouse 
RyR2 antibody (1:100; clone C3:33, Millipore, MA; raised against canine cardiac 
ryanodine receptor).  Blots were washed 3 times for ten minutes in washing buffer 
and incubated with horseradish peroxidase (HRP) linked anti-mouse secondary 
antibody (1:5000; #31430; Thermo Scientific, Glen Burnie, MD, USA) in washing 
buffer at room temperature for 1 hour.  Membranes were washed three times in 
washing buffer and developed using SuperSignal West Femto Chemiluminescent 
Substrate (Thermo Scientific) and imaged on the Syngene G:BOX using Syngene 
GeneSnap acquisition software.  
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Planar lipid bilayer electrophysiology: testing the effects of the calsenilin and 
RyRs direct protein-protein interaction on individual RyR channel activity 
 
Isolation of endoplasmic reticulum microsomes for the electrophysiological 
testing of native brain RyRs 
 C57BL/6 mouse brains (n=8-15) were thawed and washed in ice cold PBS.  
The washed brains were minced on ice in homogenization buffer (260mM sucrose, 
5mM HEPES, 1mMEGTA, 1mMDTT, and 10 µg/mL protease inhibitor cocktail 
(PMSF, aprotinin, pepstatin, trypsin inhibitor), at pH 7.35 with KOH) using a straight 
razor.  The minced tissue was then diluted in ice cold homogenization buffer, and 
placed in a Dounce glass homogenizer, homogenized for 10-15 strokes, and placed 
in an ultracentrifuge tube.  The sample was then centrifuged in a Sorvall ULTRA 80 
ultracentrifuge for 10 minutes at 1000xg to remove the nuclear fractions and cellular 
debris.  The supernatant was collected and spun at 1000xg for 10 minutes to ensure 
removal of all cellular debris and nuclear fraction.  The supernatant was collected 
and centrifuged at 5000xg (to remove mitochondrial fraction) for 10 minutes.  This 
step was repeated once more. Following the second centrifugation step, the 
supernatant was collected a further time and centrifuged at 100,000xg for 50 
minutes (to collect the ER microsomal fraction).  The supernatant was removed and 
discarded and the pellet was resuspended in homogenization buffer without EGTA, 
snap frozen in liquid nitrogen, and stored at -80oC until use.   
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Planar lipid bilayer experimental setup 
Planar lipid bilayer electrophysiology involves forming an artificial bilayer 
across an aperture which links two fluid filled chambers.  The system consists of two 
distinct chambers (Warner Instruments, Hamden, CT; see Figure 2): the cis 
chamber, representing the cytoplasm of the cell (containing 93mMTrisOH/190mM 
HEPES, (Sigma-Aldrich) pH 7.35, approx.  285 mOsm) and the trans chamber 
representing the ER lumen (containing 50mM Ba (OH) 2/245mM HEPES (Sigma-
Aldrich), pH 7.35, approx. 285 mOsm).  The trans chamber contains a bilayer cup 
with a 150µm aperture which a lipid bilayer containing phosphatidylethanolamine 
and phosphatidylserine (3:1 w/w dissolved in decane; Avanti Polar Lipids, Alabaster, 
AL) is spread across.  Prior to the spreading of the artificial bilayer, the aperture is 
primed by dispersing lipids containing phosphatidylcholine and phosphatidylserine 
(3:1 w/w dissolved in decane; Avanti Polar Lipids) within the aperture.  This priming 
prepares the aperture to receive the lipid bilayer by providing the extra lipids to 
anchor the bilayer to the bilayer cup.  Two salt agar bridges (5% agar in 1MKCL 
(Sigma) (w/v)) connect the cis and trans chamber to a headstage that transfers the 
signals to a BCD525 Warner Instruments amplifier.  After bilayer formation a 
capacitance test is then performed to access the relative thickness of the bilayer.  
The capacitance measurement allows an indirect measure of the artificial bilayer 
thickness ensuring the pore region of the receptor can pass completely through the 
bilayer.  The trans chamber is grounded and the cis chamber is clamped at 0mV.  
The integrity of the bilayer is accessed by monitoring the current between the two 
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chambers before microsome incorporation.  At this time a current of 0mV connotes a 
bilayer with no contact between chambers.   
 
 
 
Figure 2. Schematic representation of Planar lipid bilayer electrophysiology: 
experimental set up. 
Two chambers (cis and trans) are separated by a 150µm aperture in which an 
artificial bilayer is formed across.  Salt agar bridges connect the two chambers to a 
headstage that transfers the electrical activity to an amplifier.  The trans side of the 
chamber is grounded and the cis side of the chamber is clamped at a 0mV holding 
potential.   
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Testing for proper channel incorporation, stability, and experimental 
procedures for the measurement of RyRs biophysical activity 
When a stable bilayer was formed, ER microsomes containing RyRs were 
added to the cis chamber and incubated for 10-20 minutes.  The purpose of the 
incubation is to place the microsomes in a pre-fusion state where the lipids of the 
bilayer and microsome are in close proximity.  When incubation was complete, 
microsomes were fused to lipid bilayers by addition of 3M KCl.  The addition of the 
hyperosmotic solution creates an osmotic gradient and induces microsomal swelling.  
The hydrostatic pressure created within the microsome induces fusion.  Fusion is 
monitored by the appearance of channel activity.  Upon channel incorporation the cis 
chamber was washed with 10 volumes of cis solution.  To ensure all channels are 
correctly oriented with the cytoplasmic portion of the RyR facing the cis chamber the 
current carrier used is Ba2+.  Ba2+ as a charge carrier cannot activate RyR; therefore 
any channels oriented with the cytoplasmic portion facing the trans chamber will not 
be activated.  RyR currents were activated by adding Ca2+/EGTA in molar 
proportions, calculated by MaxChelator software (Stanford University) and verified 
by Ca2+ electrode measurements.  Once activated at the specific Ca2+ concentration 
to be tested, the channel activity was recorded for three minutes.  After this baseline 
activity was recorded, calsenilin recombinant protein was added to the cis side of the 
chamber and allowed to incubate with constant stirring for one minute. Following 
incubation, the channel activity was recorded for three minutes.  The range of 
calsenilin concentrations we used represents possible physiological concentrations 
of calsenilin within the cell.  All experiments were performed at room temperature.   
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Software settings for the acquisition and filtering of single channel 
experiments 
Single channel recordings were performed using BCD525 Warner 
Instruments amplifier, and filtered to reduce the amplitude of high-frequency noise at 
500Hz.  Digitization was done at 10 kHz using Digidata 1322A acquisition system 
and Molecular Devices pClamp 10 software.  Analysis of recordings was done using 
Molecular Devices ClampFit 10 software, lowpass filtered at 320 Hz to reduce lower 
frequency noise associated with digitization.  Baselines were set at zero, and single 
channel events were recorded for the conductance states of -2pA and -4pA.  
Clampfit software calculated all of the following statistics for 3 minutes of recording: 
number of events (how many times the channel opens), average amplitude (current 
for single channel opening), dwell time (the amount of time per each single channel 
opening), and open probability (the probability of a channel being open per time 
period).   
 
Comparing single channel biophysical data of RyRs in the presence and 
absence of calsenilin  
Due to the variable nature of single channel activity, all recordings were 
normalized to control values and reported as percentage of controls.  Graphpad 
prism 5 software was used for all analysis and data presentation.  Nonlinear curve 
fitting was performed using the Levenberg–Marquardt algorithm and tested for 
goodness of fit using the chi squared algorithm.  A one-way ANOVA with a Dunnett’s 
post hoc test was used to test significance (Mean ± SEM; p< 0.05*, p< 0.01**, 
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p<0.001***). One-way ANOVA analysis with a Dunnett’s post hoc test was used 
because it is the most appropriate analysis for comparing multiple groups and 
normalized data. 
 
Ca2+ imaging: to test the effect of calsenilin modulation of single RyR channels 
in a whole cell paradigm by overexpressing calsenilin in SH-SY5Y cells 
 
Overexpression of calsenilin recombinant protein in SH-SY5Y cells  
SH-SY5Y cells were grown as previously stated in section of materials and 
methods.  Cells were stripped using trypsin-EDTA as described earlier, and 2 million 
cells were used for each reaction.  Cells were co-transfected with the tdTomato to 
allow identification of transfected cells.  Cells were suspended in Lonza transfection 
media with 2 µg of calsenilin.  pcDNA3. 1 (+) Zeo mammalian expression vector and 
0.5 µg of tdTomato (reporter protein) pcDNA3.1 (+) Zeo mammalian expression 
vector, then transfected using a Lonza 4D-nucleofector transfection unit.  After 
transfection was carried out, the cells were plated at 25,000 cells per laminin/poly-d-
lysine coverslip and maintained for 36-48  hours, and subsequently used for Ca2+ 
imaging experiments.   
 
Verification of co-transfection using fluorescent markers  
 SH-SY5Y cells were co-transfection with green fluorescent protein (GFP; 
emission wavelength 509nm) and tdTomato fluorescent protein (emission 
wavelength 581nm) in order to verify the transfection protocol (described in the 
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preceding section).  The ratio of GFP: tdTomato plasmid co-transfection was the 
same as that used for calsenilin: tdTomato.  The cells were then fixed and imaged 
as previously stated.  Figure 3 shows that all cells expressing the fluorescent marker 
tdTomato also express the GFP fluorescent marker.  These results verify that cells 
are successfully transfected using our protocol, and that GFP can be used as a 
transfection-verification tool. 
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Figure 3.  Validation of Co-transfection using fluorescent markers.   
Co-transfection of GFP and tdTomato fluorescent markers into SH-SY5Y cells 
verifies that all cells transfected with the fluorescent marker protein (tdTomato) are 
also transfected with the GFP protein (ratio GFP: tdTomato 4:1).  The first panel 
shows transfected cells with GFP fluorescence, the second panel shows tdTomato 
fluorescence, and the third panel displays an overlay of the two fluorescent signals.  
The arrows indicate representative cells showing similar levels of expression for both 
proteins.   
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Verification of tdTomato as an indicator for overexpression of calsenilin in 
cells using confocal microscopy 
SH-SY5Y cells were co-transfected with calsenilin (no emission or 
fluorescence) and tdTomato (emission wavelength 581nm) plasmids were prepared, 
stained using immunocytochemistry, and imaged (see earlier section describing the 
immunocytochemistry protocol).  Images were processed using the Image J heat 
map plugin which measures relative fluorescent values of specified channels and 
displays results using a color coded figure legend.  Figure 4 shows cells that are 
tdTomato positive have a higher calsenilin expression level that cells that are 
tdTomato negative.  The calsenilin expression in cells that are tdTomato negative 
are likely to be endogenous levels of calsenilin as they are expected to be 
untransfected.  These results verify that by co-transfecting the cells with tdTomato 
enables visualization of the transfected cells with a fluorescent marker, making it 
possible to distinguish between successful transfection of calsenilin and 
consequently enabling selection of calsenilin overexpressing cells.  Therefore, based 
on this rationale, only cells that were tdTomato positive (fluorescing cells) were 
chosen for Ca2+ imaging experiments.   
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Figure 4. Confocal images showing tdTomato incorporation as an indicator for 
successful calsenilin transfection in SH-SY5Y cells.   
SH-SY5Y cells co-transfected with calsenilin and tdTomato showed that tdTomato 
positive cells display increased calsenilin expression compared to cells absent of 
tdTomato.  The first panel displays calsenilin expression, the second panel tdTomato 
expression, and the third panel displays and overlay of the two channels.  The heat 
map shows that the cells expressing tdTomato have an increased expression of 
calsenilin as opposed to cells showing no tdTomato expression.  The two red arrows 
in the heat map panel indicate expression of calsenilin.  The fifth panel is an overlay 
plus the nuclear stain DAPI, indicating that overexpression of calsenilin does not 
alter the perinuclear expression pattern.   
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Calibration of the Fura-2 Ca2+ indicator dye Kd for Ca
2+ binding in order to 
accurately translate changes in fluorescence to biological changes in Ca2+ 
concentration 
Fura-2 pentapotassium salt (Life Technologies) Ca2+ indicator dye was used 
as an in vitro calibration for  Kd  calculations that mimicked experimental conditions of 
pH 7.35, temperature of 37oC, and imaged on a Leica DM6000 FS fluorescent 
microscope (Leica, Wetzlar, Germany) with an Orca-R2 C10600 digital camera 
(Hamamatsu, Bridgewater, NJ) and DG5 illuminator and fast wavelength switcher  
(Sutter, Novato, CA) controlled by MetaFluor (Molecular Devices, Sunnyvale, CA), 
Fura-2 filter set 71000av2 (D340xv2, D380xv2, 400DCLP, D510/40m; Chroma, 
Bellows Falls, V)  with a HCX PL APO 40x/1.25-0.75 oil objective (Leica, Wetzlar, 
Germany).  Collection of the ratiometric fluorescent dye Fura-2 was done by exciting 
alternately at 340nm and 380nm and collecting at 510nm.  Fluorescent values were 
calculated using a 340nm/380nm ratio which indicates the change in Ca2+ 
concentration.  Cell free calibration of Fura-2 was done to achieve relative values of 
Ca2+ concentration for changes in fluorescence within these experimental conditions, 
as opposed to absolute values that would be achieved using a cell based calibration.  
The in vitro calibration was used to ensure that the minimum value of the fluorophore 
was achieved Reciprocal dilutions were used to calibrate Fura-2 Ca2+ indicator dye.  
This technique is based on the notion that defines free [Ca2+] as the Kd of EGTA at a 
particular pH, temperature, and osmolarity when Ca2+ and EGTA concentrations are 
equitably close [176].  To ensure the purity of compounds used in the calibration, a 
commercially available calibration kit was used (calibration buffer kit # 1; Invitrogen).  
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The amount of free Ca2+ was calculated by the ratio of supplied K2 EGTA (10mM) 
and CaEGTA (10mM), added to fixed amount of Fura-2 pentapotassium salt.  The 
free Ca2+ concentrations tested were 0, 0.006µM, 0.0137µM, 0.0234µM, 0.0365µM, 
0.0547µM, 0.0821µM, 0.128µM, 0.219µM, 0.492µM, and 36µM.  Ratio 
measurements at 0µM and 36µM were considered min and max values, 
respectively.  K2 EGTA (10mM) and CaEGTA (10mM) solutions with Fura-2 
pentapotassium salt (2µM) were brought to a pH of 7.35, a temperature of 37oC, and 
placed on the microscope for data collection.  Ratios of K2 EGTA (10mM) and 
CaEGTA (10mM) solutions with 2µM Fura-2 pentapotassium salt were sequentially 
added and measured for all free Ca2+ values mentioned.  After collection, values 
were plotted as the log of free Ca2+ concentrations (X-axis) and the log of (F-Fmin)/ 
(Fmax-F) (y-axis).  The double log plot gives an x-intercept that is the log of the Kd of 
Fura-2 (see Figure 5).  The slope of 1 reflects the 1:1 binding of fura-2 with Ca2+ 
(Figure 5).  The in vitro Kd of Fura-2 in these conditions was calculated to be 0.118 
µM.   
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Figure 5.  Calculated graph for the calibration of Fura-2 Kd value.   
The y-axis displays the log of the bound/ free Ca2+ as reported by the fluorescent 
ratio of Fura-2 (340nm/380nm).  The x-axis is the log of the free Ca2+ as calculated 
previously using the Kd of EGTA and a known ratio of Ca
2+ /EGTA   (x-axis; 
0.006µM, 0.137µM, 0.234µM, 0.365µM, 0.547µM, 0.821µM, 0.128µM, 0.219µM, 
0.492µM) at a pH of 7.35 and temperature of 37°C.  The x-intercept represents the 
log of the Kd of Fura-2.   
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Ca2+ imaging: Quantifying the effect of calsenilin and RyR interaction on Ca2+ 
release in calsenilin-transfected SH-SY5Y cells 
The media from mock- or calsenilin-transfected SH-SY5Y cells (maintained, 
plated and transfected as described in previous sections) was removed and washed 
in extracellular solution buffer (ECS; 137mM NaCl, 5mM KCl, 1mM Na2HPO4, 1mM 
MgSO4 (anhydrous), 10mM HEPES, 22mM D-(+)-glucose, and 1.8mM CaCl2 
(anhydrous); 7.3pH at 37°C) three times, then incubated in 2µM fura-2 AM 
(Invitrogen) in ECS for 30 minutes.  Coverslips were then washed with ECS 
containing 55mM KCl to empty and subsequently refill their intracellular Ca2+ stores, 
then washed a further two times with ECS.  Coverslips were assembled to the 
imaging platform as previously described, and continually perfused with ECS at a 
constant temperature of 37°C by Temperature Controller TC-344B (Warner 
Instruments, Hamden, CT) and SC-20 inline heater/cooler (Warner Instruments).  
ECS containing caffeine (30mM, caffeine is a selective ryanodine receptor activator 
[175]) was perfused using VC-8T perfusion system (Warner Instruments, Hamden, 
CT) by MetaFluor and driven by P720/66 high flow peristaltic pumps (Instech, 
Plymouth Meeting, PA) at 2ml/minute.  Time from perfusion channel opening to full 
chamber incubation was consistently measured at approximately 60 seconds.  
Perfusion protocols were the same for all experiments and controlled through 
MetaFluor sequential journals.  The perfusion protocol was a simple 3 step 
sequence: 1 minute of ECS to establish a baseline, 3 minutes of 30mM caffeine in 
ECS to stimulate the RyRs, 3 minute of ECS to return the response to baseline (see 
Figure 6).  Regions of Interest (ROIs) were selected following Ca2+ imaging, in order 
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to adjust for drift, and background ROI’s (N=4 for each coverslip) were selected 
using a region of the optical field not occupied by cells.  
 
 
 
  
 
 
Figure 6. Representative video samples of caffeine-induced Ca2+ release during live 
cell Ca2+ imaging in SH-SY5Y cells 
Representative images from calcium imaging experiments to show the fluorescent 
change in control SH-SY5Y cells following caffeine-induced calcium release. 
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Transformation and comparison analysis of Ca2+ imaging experiments utilizing 
quantitative calculated   Ca2+ values 
 For each time point in the experiment protocol, the fluorescent values for 
excitation at 380nm (Ca2+ free Fura-2 indicator) and 340nm (Ca2+ bound Fura-2) 
were collected at 510nm.  Background values were subtracted from raw fluorescent 
values to ensure only accurate signals was analyzed. Next, the ratio of bound to 
unbound Ca2+ indicator dye was calculated.  The ratio of 340/380 allowed the 
calculation of R which describes the ratio of bound fluorescent indicator at each time 
point.  The formula [Ca2+] = Kd*(R-Rmin)/(Rmax-R)*F380min/F380max (Kd of Fura-2 = 
0.118 µM; calculated as described earlier; R= 340/380 for each experimental time 
point;  Rmin = the 340/380 at 0 free Ca
2+; Rmax = the 340/380  at saturating free Ca
2+ ; 
F380min = the fluorescent intensity of 380nm at 0 free Ca
2+; and F380max = the 
fluorescent intensity of 380nm at saturating free Ca2+) was used to calculate the 
quantitative Ca2+ concentration at each point (Note: All values in the formula were 
kept constant except for the experimental value of R). The formula used describes 
the interrelationship of free Ca2+ and the ratio of fluorescent intensities. The 
transformation of the data allows a more sensitive indicator of smaller changes in 
[Ca2+].  Data sets were normalized by using [Ca2+}/[Ca2+]0 calculations, [Ca
2+]0 being 
the calculated Ca2+ values for the first minute of recording (baseline), and [Ca2+] 
being the calculated Ca2+ values each time point. The following example calculation 
shows the increased sensitivity gained by transforming qualitative fluorescent 
signals to quantitative [Ca2+].  
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E.g. Using the same F and F0 values, the qualitative estimate of caffeine-evoked 
Ca2+ response (F/F0) and quantitative free [Ca
2+] conversions can be calculated: 
 
F = maximum caffeine-evoked fluorescence signal = 0.074 
F0 = baseline = 0.063 
 
A) The calculation F/F0 can be used to obtain a qualitative estimate of the 
change in fluorescence over baseline after caffeine stimulation : 
 
F/F0 = 0.074/0.063 = 1.17 
 
B) The conversion of the qualitative fluorescent signals to quantitative free 
[Ca2+] more accurately describes the physiological changes due to smaller 
incremental increases in Ca2+: 
 
i) The following constants obtained from the calibration curve (Fig 5): 
Kd of Fura-2 = 0.118uM 
Rmin = 0.033 
Rmax = 1.33 
F380min = 132.08 
F380max = 9.87 
 
ii) Substitute constants, F, and F0 into free [Ca
2+] conversion formula: 
 
[Ca2+] of F = [Ca2+] = Kd*(F-Rmin)/ (Rmax-F)* F380min / F380max 
 
 
[Ca2+] = 0.118(0.074-0.033)/ (1.33-0.074)*(132.08/9.87) 
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 = 0.118 (0.041/1.256)*13.38 
 = 0.118*0.033*13.38 
 = 0.052 
 
[Ca2+] of F0 = [Ca
2+]0 = 0.118(0.063-0.033)/ (1.33-0.063)*(132.08/9.87) 
 = 0.118 (0.03/1.267)*13.38 
 = 0.118*0.024*13.38 
 = 0.038 
 
iii) Therefore, the change in [Ca2+] over baseline after caffeine stimulation   
is: 
 
[Ca2+]/ [Ca2+]0 = 0.052/0.038 = 1.37 
 
 
By transforming the qualitative fluorescent values to quantitative Ca2+ values 
the changes evoked by caffeine induced Ca2+ release become more biologically 
meaningful. Though the relationship between the signals is not altered, a small 
change in fluorescence equates to a larger change in Ca2+ concentration. Fura-2 is 
sensitive to small changes in Ca2+ concentration, which reflects the same sensitivity 
of cellular processes to minute changes in Ca2+ concentration. Therefore, the 
transformation of qualitative fluorescent values to quantitative Ca2+ concentrations 
more accurately reflects the magnitude of change in a cell after caffeine induced 
Ca2+ release. 
 
Graphpad prism 5 software was used for all analysis and data presentation.  
The calculation for the area under the curve (AUC) was defined as follows: the 
beginning of the curve was the time point where the Ca2+ value rose above 5% of 
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baseline and the ending of the curve was defined by the last point in the curve that 
was above 5% of baseline.  Both maximum value and width of response were 
calculated from this curve also.  Linear regression was done to calculate the slope 
values of each response (which represents the rate of Ca2+ release for each 
experiment) using the max value and the first point 5% above baseline.  All values 
were averaged and statistically analyzed using the student’s t-test (Mean ± SEM, p< 
0.05*, p< 0.01**, p<0.001***).   
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CHAPTER 3 
RESULTS 
 
 The expression patterns of calsenilin and RyRs in neuronal tissue were 
compared and quantified using immunocytochemistry (SH-SY5Y cells and E18 
cortical neurons) and immunohistochemistry (brain sections).  To establish if 
colocalization translates to a direct protein-protein interaction co-
immunoprecipitation of calsenilin and neuronal RyRs were carried out. Subsequent 
Western blot analyses of precipitated proteins were identified using protein weight 
estimation.  Single channel electrophysiology and live-cell optical imaging 
techniques were used to determine the mechanisms of intracellular Ca2+ signaling 
controlled by the interaction of calsenilin and RyRs, including changes in the release 
of Ca2+ from intracellular stores.  Immunocytochemistry or immunohistochemistry 
verified the biological relevance of this interaction by showing that calsenilin and 
RyR2 or RyR3 are co-localized in neuronal cells. Co-immunoprecipitation studies 
established a direct link between the two proteins of interest.  To better understand 
the functional consequences of a calsenilin and RyR interaction the biophysical 
parameters of RyR Ca2+ release were measured in the presence of calsenilin. Single 
channel kinetics was measured using planar lipid bilayer electrophysiology. The 
modulation of Ca2+ release in a population of RyRs was tested by overexpressing 
calsenilin (transfection) in a whole cell model and imaging the release of Ca2+ 
through live cell optical imaging techniques.   
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Calsenilin and RyR2 and RyR3 co-localized in rat primary cortical neurons and 
SH-SY5Y cells 
 
Immunoreactivity for calsenilin and RyR2 (Fig 7A), and calsenilin and RyR3 
(Fig 7B) shows a punctate distribution pattern indicative of perinuclear endoplasmic 
reticulum staining [68, 149, 172].  These expression patterns were similar in primary 
cortical neurons (Fig 7A and 7B) and SH-SY5Y neuroblastoma cells (Fig 8A and 
8B).  Pearson’s coefficient values (Table 1) for both primary neurons and 
neuroblastoma cells describe a moderate linear relationship characterizing two 
proteins that interact in the perinuclear regions of the cells, but diverge when located 
elsewhere.  The Mander’s coefficient values of calsenilin and RyR (Table 1) are 
between 30%-60% showing these proteins occupy the same region within the cell, 
but have a wide distribution throughout the cell.   
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Figure 7.  Calsenilin and RyR immunoreactivity and co-localization pattern in cortical neurons.   
Calsenilin and A) RyR2 or B) RyR3 immunoreactivity in E18 primary cultured cortical neurons shows co-localization in 
regions adjacent to the nucleus indicative of endoplasmic reticulum staining.  A)  Calsenilin immunoreactivity (green) 
and RyR2 immunoreactivity (red) shows a perinuclear staining pattern (Merge)  and a high degree of  punctate  co-
localization in the perinuclear region (+PDM) as indicated by arrows and LUT in the last panel.  B) Calsenilin 
immunoreactivity (green) and RyR3 immunoreactivity (red) shows a perinuclear staining pattern (Merge) and a high 
degree of punctate co-localization in the perinuclear region (+PDM) as indicated by arrows and LUT legend in the last 
panel.   
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Figure 8.  Calsenilin and RyR immunoreactivity and co-localization pattern in SH-SY5Y cells.   
Calsenilin and A) RyR 2 or B) RyR 3 immunoreactivity in SH-SY5Y  neuroblastoma cells shows co-localization in 
regions adjacent to the nucleus indicative of endoplasmic reticulum staining  A) Calsenilin immunoreactivity (green) 
and RyR 2 immunoreactivity (red) shows a perinuclear staining pattern (Merge)  and co-localization in the perinuclear 
region (+PDM)  as indicated by arrows and LUT in the last panel B) Calsenilin immunoreactivity (green) and RyR 3 
immunoreactivity (red) shows a perinuclear staining pattern (Merge) and a high degree of  punctate  co-localization in 
the perinuclear region (+PDM) as indicated by arrows and LUT in the last panel.   
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Calsenilin and RyR2 and RyR3 co-localize in the hippocampus and cortex  
 
In the mouse brain, co-localization of calsenilin and RyR2 or RyR3 in the 
dentate gyrus, CA3 and CA1 of the hippocampus and II/III, V, and VI layer of the 
cortex showed differing degrees of co-localization for the two channel subtypes 
tested.  Hippocampal immunoreactivity of RyR2 and calsenilin was similar to cellular 
studies, as represented by the dentate gyrus staining (Fig 9A).  As shown in Table 1, 
Pearson’s coefficient and Mander’s coefficient values in brain tissue are similar to 
that of the cellular studies performed in this study, indicating that the distribution and 
co-localization of these two proteins are similar in vitro as well as in vivo.  
Immunoreactivity of RyR2 and calsenilin in the cortical layers shows a similar pattern 
of expression and co-localization, represented by cortical layer VI staining (Fig 9B), 
as seen in earlier experiments.  Rr, M1, and M2 values are in accordance with those 
in the hippocampal areas, with the Rr values being slightly higher in all cortical levels 
tested (Table 1).  RyR3 and calsenilin co-localization showed a differential 
distribution depending on brain region.  The CA3 region of the hippocampus (Fig 
10A) showed a higher degree of co-localization than the dentate gyrus (Fig 10B) and 
the CA1 regions (Table 1).  In the cortical regions layer VI (Fig 11A), RyR3 and 
calsenilin showed a greater linear relationship than layers II/III (Fig 11B; Table 1).   
To conclude, these results indicate that calsenilin and RyR expression 
overlap, with a specific ER-type expression pattern.  In order to determine if this co-
localization correlates to a direct protein-protein interaction, we incubated RyR-rich 
microsomes and recombinant calsenilin protein together. Using co-
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immunoprecipitation to pull-down RyR complexes present in the mixture was 
visualized using western blot analysis. 
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Figure 9. Calsenilin and RyR 2 immunoreactivity and co-localization pattern in the dentate gyrus and cortical layer VI.   
Calsenilin and RyR2 immunoreactivity in the dentate gyrus and cortical layer VI of C57BL/6 mouse brain shows co-
localization in adjacent regions to the nucleus, indicative of endoplasmic reticulum staining.  A) Calsenilin 
immunoreactivity (green) and RyR2 immunoreactivity (red) in the dentate gyrus shows a perinuclear staining pattern 
and a co-localization (Merge) as indicated by arrows and (+PDM)  LUT in the last panel.  B) Calsenilin 
immunoreactivity (green) and RyR2 immunoreactivity (red) in layer VI of the cortex shows perinuclear, dendritic, and 
axonal staining patterns (Merge) with a high degree of punctate co-localization in the perinuclear region and at the 
base of processes (+PDM) , indicated by arrows and LUT in the last panel.   
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Figure 10. Calsenilin and RyR3 immunoreactivity and co-localization pattern in the dentate gyrus and CA3 region.   
Calsenilin and RyR3 co-localization in C57BL/6 mouse brain is region specific with the A) CA3 region of the 
hippocampus showing higher degree of co-localization than the B) dentate gyrus.  A) Calsenilin immunoreactivity 
(green) and RyR2 immunoreactivity (red) in the CA3 region shows a staining throughout the CA3 cells (Merge) and a 
high degree of co-localization, as indicated by arrows and (+PDM) LUT in the last panel.  B) Calsenilin 
immunoreactivity (green) and RyR2 immunoreactivity (red) in the dentate gyrus shows staining in clusters of cells 
(Merge) with a moderate degree of co-localization, as indicated by arrows and (+PDM)  LUT in the last panel.   
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Figure 11. Calsenilin and RyR3 immunoreactivity and co-localization pattern in Cortical layer VI and II/III.   
Calsenilin and RyR 3 co-localization in C57BL/6 mouse brain is region specific with A) cortical layer VI showing higher 
degree of co-localization than B) cortical layer II/III.  A) Calsenilin immunoreactivity (green) and RyR2 immunoreactivity 
(red) in cortical layer VI shows perinuclear staining (Merge) and a high degree of co-localization, as indicated by 
arrows and (+PDM) LUT in the last panel.  B) Calsenilin immunoreactivity (green) and RyR2 immunoreactivity (red) in 
cortical layer II/III shows slight staining (Merge) with a moderate degree of co-localization, as indicated by arrows and 
(+PDM) LUT in the last panel.   
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Table 1. Pearson’s and Mander’s values of co-localization for calsenilin and RyR subtypes.   
Co-localization measurements between calsenilin and RyR2 or RyR3 for neuronal cell types (E18 primary cortical 
neurons and SH-SY5Y neuroblastoma cells) and 6wk old C57BL/6 mouse brain sections (dentate gyrus, CA3, CA1, 
cortical layers II/III, V, VI).  The Rr = Pearson’s coefficient and M1=Mander’s coefficient describe the amount of 
calsenilin co-localized with the two RyR subtypes, whereas the M2= Mander’s coefficient describes the amount of the 
RyR2 or RyR3 co-localized with calsenilin.  Statistical significance represents the SEM for each replicate; co-
localization was tested with the Costes method to ensure true co-localization.  For calsenilin/RyR2 co-localization 
(values on left of table), Rr, M1, and M2 for both cell types and tissue tested were similar, with cortical layers V and VI 
showing higher Rr values.  For calsenilin/RyR3 co-localization (values on right of table), R2, M1 and M2 values for cell 
types, hippocampal region CA3, cortical layer VI showed similar values, while all values for the dentate gyrus, CA1, 
cortical layer II/III, and V were similar but at lower values than the other brain regions.  Values are represented as 
Mean ± SEM.   
 RyR2 RyR3 
Sample Rr M1 M2 Rr M1 M2 
Cell type 
      
    Cortical Neurons 0.156 ± 0.022 0.504 ± 0.069 0.501 ± 0.037 0.209 ± 0.015 0.396 ± 0.033 0.437 ± 0.024 
    SH-SY5Y 0.155 ± 0.030 0.557 ± 0.079 0.601 ± 0.043 0.166 ± 0.008 0.468 ± 0.042 0.520 ± 0.033 
Brain Region 
      
    DG 0.131 ± 0.025 0.650 ± 0.061 0.460 ± 0.089 0.034 ± 0.043 0.424 ± 0.085 0.243 ± 0.106 
    CA3 0.138 ± 0.024 0.447 ± 0.075 0.493 ± 0.063 0.148 ± 0.038 0.288 ± 0.047 0.117 ± 0.023 
    CA1 0.122 ± 0.025 0.594 ± 0.059 0.587 ± 0.079 0.081 ± 0.018 0.393 ± 0.080 0.234 ± 0.076 
    Ctx II/III 0.178 ± 0.031 0.436 ± 0.065 0.355 ± 0.083 0.044 ± 0.007 0.199 ± 0.027 0.042 ± 0.004 
    Ctx V 0.259 ± 0.023 0.470 ± 0.050 0.445 ± 0.096 0.055 ± 0.007 0.201 ± 0.030 0.057 ± 0.013 
    Ctx VI 0.275 ± 0.033 0.416 ± 0.056 0.384 ± 0.066 0.111 ± 0.037 0.175 ± 0.014 0.054 ± 0.005 
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Calsenilin recombinant protein co-immunoprecipitates with RyR2, verified by 
Western blot analysis  
 
Following co-immunoprecipitation, the RyR2 antibody successfully captured 
the RyR-calsenilin protein complex. The immunoblot in Figure 12 shows a calsenilin 
band at 51kDa (calsenilin recombinant protein + GST tag) and a RyR band at 
approximately 550kDa.  IgG is detected in immunoblots at approximately 51kDa.  To 
control for artificial positives on the immunoblot from pulldown antibody IgG, the 
antibody used to label immunoblots was derived from a different species than the 
precipitating antibody.  By using a different species of antibody we can be certain 
that the band seen at the 51kDa weight marker is calsenilin with the GST tag. The 
IgG control showed no distinguishable band in either the RyR or calsenilin region of 
the immunoblot.  Pull-down assays with brain microsomes absent of recombinant 
protein, showed no distinguishable bands due to protein levels being below 
detection levels of the immunoblot.  Pull-down assays with whole brain preparations 
were marred with several unspecific protein bands and smears due to fatty content 
of the brain.  Densitometric analysis of immunoblot bands with RyRs as the loading 
control showed saturation of RyR binding at 60nM-100nM. Revealing an 
approximate 1:1 ratio of expression for the RyR: calsenilin signal.  Reverse pulldown 
assays using the calsenilin antibody as the pulldown antibody did not yield bands in 
immunoblots possibly due to weak electrostatic interactions between the two 
proteins from localized charges on their surfaces.  The concentration of 60nM which 
yields approximately a 1:1 ratio in densiometric studies in reminiscent of the binding 
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ratio between Kv4.2 channels and calsenilin.  Calsenilin alters the release kinetics of 
the Kv4.2 channel, so we tested the effect of this protein-protein interaction using 
60nM recombinant calsenilin protein using planar lipid bilayer electrophysiology.   
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Figure 12.  Western blot showing RyR2 and calsenilin protein, from a pulldown using 
RyR2 antibody.   
Co-immunoprecipitation using rabbit anti-RyR antibody (1:200; #AB9080; Millipore) 
or control rabbit IgG (2mg/ml magnetic beads) in brain derived ER microsomes with 
increasing levels of calsenilin recombinant protein (0-100nM).  Calsenilin is detected 
at 51kDa due to GST tag on the calsenilin recombinant protein that was added.  No 
bands were seen using IgG as the precipitating antibody as viewed in the first lane.   
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Electrophysiological recordings show calsenilin reduces the amount of time 
that the RyR conducts ions during a given period of time at low intracellular 
Ca2+ 
 
Figure 13 shows a representative long (30s) and short (4s) continuous 
recording of RyR channel activity. The 4s trace is labeled with the different 
parameters measured in single channel electrophysiology. The average amplitude 
describes the unique conductance property of RyRs. RyRs have three conductance 
states, a closed conductance state represented by the baseline label, a partially 
open state represented by the S2 label, and a fully opened state represented by the 
S4 label.  The amplitude reflects the consequence of the conductance state where a 
closed state (baseline) = 0pA, a partially open state (S2) = -2pA, and a fully open 
state (S4) = -4pA.  These descriptions are important as they are all used in 
assessing open probability of the channel over time.  As seen in figures 15A and 
13B, at low (100nM) intracellular Ca2+ (pCa7), 60nM calsenilin decreases the activity 
of the receptor as noted by less downward deflections in figure 15B as opposed to 
15A.  This decrease in activity is represented in figure 14A by a significant decrease 
in the time that the RyR channel will be open at any given period of time reflected by 
a decrease in open probability.  There is a significant decrease in the open 
probability of the S2 state (Fig 14A).  The mechanism of this decrease in channel 
activity can be attributed to a decrease in the number of times the receptor opens at 
S2 conductance state as indicated by a downward shift in the amplitude histogram 
(Fig15B) as well as decrease in the amount of time the channel remains open each 
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time it is activated as indicated by a leftward shift in the dwell time histogram 
(Fig15C).   
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Figure 13. Representative single channel recordings of planar lipid bilayer 
electrophysiology.   
 
Representative single channel recordings of long 30s (A) and short 4s (B) recordings 
showing representative example of baseline and conductance states average 
amplitude S2 (io =-2pA), S4 (io =-4pA), event, and dwell time.   
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Figure 14.  Calsenilin increases the open probability of RyR single channel activity at 
higher activity intracellular Ca2+ levels.   
Calsenilin increases the open probability of RyR single channel activity at higher 
activity intracellular Ca2+ levels, but decreases the open probability of RyR single 
channel activity at low activity intracellular Ca2+ levels.  After treatment with 60nM 
calsenilin the open probability for A) io=-2pA sublevel for pCa7 was decreased, while 
pCa6 was increased, but for B) io=-4pA both pCa6 and pCa5 open probability was 
increased.  The number of channels averaged for each condition is presented at the 
bottom of each column bar.  Significance parameters were obtained using Dunnett’s 
Multiple Comparison Test.  Values represented as Mean SEM ***p<0.001, **p<0.01, 
n=3-8.   
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Figure 15.  Calsenilin causes a downward shift in the amplitude histogram and a 
leftward shift in the dwell time histogram of RyR at pCa7.   
(A) Current traces (60s continuous recordings) representing open channel states of 
RyR before (top) and after (bottom) addition of 60nM calsenilin.  (B) Representative 
amplitude histogram curve fitted to a fourth order polynomial distribution with R2 
values of 0.591 (for pCa7) and 0.586 (for pCa7 + 60nM calsenilin) showing a 
downward shift in the amplitude histogram characterizing a decrease in the number 
of subconductance (io =-2pA) channel openings after treatment with 60nM calsenilin, 
(C) Dwell time histogram curve fitted to a Gaussian distribution with R2 values of 
0.817 (for pCa7) and 0.986 (for pCa7 + 60nM calsenilin) calculated from same 60s 
recording showing a leftward shift in dwell time histogram indicative of a decrease in 
the number of longer channel openings after treatment with 60nM calsenilin.   
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Electrophysiological recordings show calsenilin increases the amount of time 
that the RyR conducts ions during a given period of time at high intracellular 
Ca2+ 
  
At higher activity intracellular Ca2+ (pCa6), there is an increase in the open 
probability of both the low S2 (Fig14A) and high S4 conductance states (Fig 14B).  
As can be seen in a representative 30s continuous trace (Fig 16A), the activity of the 
receptor is significantly increased in the presence of 60nM calsenilin.  The 
mechanism of this potentiation can be demonstrated by the increase in the number 
of times the receptor opens at both S2 and S4 conductance states, indicated by the 
upward shift in the amplitude histogram (Fig 16B), as well as an increase in the 
amount of time the channel stays open each time it is activated, shown by a 
rightward shift in the dwell time histogram (Fig 16C).  At the highest activity 
intracellular Ca2+ (pCa5), 60nM calsenilin significantly increases the probability that 
the channel will be open in the high S4 conductance state (Fig 14B).  This increase 
in the activity of the receptor can be seen in a representative 30s continuous trace 
(Fig 17A), and can be attributed to an overall increase in the number of events that 
occur as indicated by an upward shift in both the amplitude (Fig 17B) and dwell time 
(Fig 17C) histograms.   
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Figure 16.  Calsenilin causes an upward shift in the amplitude histogram and a 
rightward shift in the dwell time histogram of RyR at pCa6.   
 
A) Current traces (60s continuous recordings) representing open channel states of 
RyR before (top) and after (bottom) addition of 60nM calsenilin, (B) representative 
amplitude histogram curve fitted to a fourth order polynomial distribution with R2 
values of 0.157 (for pCa6) and 0.171 (for pCa 6 + 60nM calsenilin) showing an 
upward shift in the amplitude histogram characterizing an increase in the number of 
subconductance (io =-2pA) and conductance (io =-4pA) channel openings after 
treatment with 60nM calsenilin.  (C) Dwell time histogram curve fitted to a Gaussian 
distribution with R2 values of  0.968 (for pCa6) and 0.926 (for pCa 6 + 60nM 
calsenilin) calculated from same 60s recording showing a rightward shift in dwell 
time histogram indicative of an increase in the number of longer channel openings 
after treatment with 60nM calsenilin. 
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Figure 17.  Calsenilin causes an upward shift in the amplitude histogram and a 
rightward shift in the dwell time histogram at pCa5.   
 (A) Current traces (60s continuous recordings representing open channel states of 
RyR before (top) and after (bottom) addition of 60nM calsenilin.  (B) Representative 
amplitude histogram curve fitted to a Fourth Order Polynomial distribution with R2 
values of.  800 (for pCa5) and 842 (for pCa 5 + 60nM calsenilin) showing an upward 
shift in the amplitude histogram characterizing an increase in the number of 
conductance (io =-4pA) channel openings after treatment with 60nM calsenilin (C) 
Dwell time histogram curve fitted to a Gaussian distribution with R2 values of  0.866 
(for pCa5) and 0.871 (for pCa 5 + 60nM calsenilin) calculated from same 60s 
recording showing a slight rightward shift in dwell time histogram indicative of an 
increase in the number of longer channel openings after treatment with 60nM 
calsenilin.   
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Overexpression of calsenilin in SH-SY5Y cells caused faster kinetics of 
caffeine –induced Ca2+ release, but not the amount of Ca2+ released 
 
Figure 18 shows an averaged change in Ca2+ [Ca2+]/[Ca2+]0 following caffeine 
induced Ca2+ release in mock- and calsenilin-transfected cells. Overexpression of 
calsenilin sharpens the Ca2+ release by increasing the rate of release (Fig 19A), 
indicated by steep increase in the [Ca2+]/[Ca2+]0  slope, and decreasing the overall 
Ca2+ response time (Fig 19C).  There was an increase in the maximum amplitude of 
the Ca2+ response (Fig 19B), but no difference in the area under the curve (Fig 19D).  
The lack of difference in the area under the curve shows that there was no 
difference in the relative level of Ca2+ release, while the increase in the maximum 
amplitude of Ca2+ release supports a faster more precise signal due to calsenilin 
overexpression.   
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Figure 18. Representative Ca2+ response to caffeine stimulation in control and 
calsenilin overexpressing SH-SY5Y cells.   
Representative response of SH-SY5Y cells to caffeine stimulation in control and 
calsenilin overexpressed cells as represented by change in [Ca2+].  A response is 
represented by [Ca2+]/[Ca2+]0 ([Ca
2+]0=baseline, [Ca
2+]=response) to normalize 
experiments for comparison.  Calsenilin causes a sharpening of Ca2+ release in 
response to Ca2+ as seen by a steep increase and shorter duration of caffeine-
induced Ca2+-release and increased magnitude of response compared with control 
cells with endogenous levels of calsenilin.   
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Figure 19. Quantification of caffeine induced Ca2+ release kinetics in control and 
calsenilin overexpressing SH-SY5Y cells.   
Column graphs representing the A) slope B) maximum amplitude C) curve width D) 
area under the curve (AUC) of caffeine-induced Ca2+-release kinetics in control 
(black columns) and calsenilin overexpression (white columns) of SH-SY5Y cells.  
Values represent averages of several experiments (N=8 for Control, and N=12 for 
calsenilin overexpression; each N represents 3-20 replicates) with a linear 
regression fit of the points between 5% above baseline and maximum [Ca2+]/[Ca2+]0 
values of the Ca2+ release slope The beginning of a Ca2+ response is defined as 5% 
above baseline and ending of a response is defined as below 5% of baseline. (Chi 
square values for best fit; control R2=0.746, overexpression R2=0.8431).  
Overexpression of calsenilin significantly increases the rate of Ca2+ release (slope) 
and the maximum amount of Ca2+ released (max amplitude), while decreasing the 
time of the Ca2+ release (curve width), however the total amount of Ca2+ released 
(AUC) remains unchanged suggesting a sharpening of the Ca2+ response without 
altering the amount of Ca2+ release.  Values were statistically analyzed using a 
student’s t-test (Mean ± SEM, p< 0.05*, p< 0.01**) 
 
 77 
 
Overview: summary of results  
 
The current study has shown through immunostaining and confocal 
microscopy that brain RyRs and calsenilin are located within the ER in neuronal 
cells.  These two proteins physically interact as shown in co-immunoprecipitation 
studies.  This interaction leads to a decrease in single channel Ca2+ release activity 
of brain RyRs at low Ca2+ concentrations (pCa7) through a decrease in the number 
of times the channel opens and a decrease in time that the channel stays open each 
time.  Conversely, this interaction at high Ca2+ concentrations (pCa6 and pCa5) 
leads to an increase in single channel Ca2+ release activity of brain RyRs through an 
increase in the number of times the channel opens at all amplitudes, and an increase  
in time the channel stays open.  This change in single channel biophysics was 
confirmed using optical Ca2+ imaging techniques, where increased calsenilin 
expression led to faster Ca2+ release, higher maximum release, and a shorter 
duration of release.  Interestingly, these changes did not alter the overall amount of 
Ca2+ release as quantified by AUC.  To conclude, calsenilin appears to sharpen Ca2+ 
release from the channel by shifting the Ca2+ activation of RyRs to a higher Ca2+ 
concentration, and increasing the channel kinetics following activation direct 
modulatory effect of calsenilin on neuronal RyRs.   
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CHAPTER 4 
DISCUSSION 
  
Limitations and considerations of experimental techniques and set up 
 
 Each of the methods used in the current study suffer from inherent technical 
limitations. By designing an experimental approach that utilizes several different 
techniques we have attempted to address these shortcomings. The evidence 
provided from the results of each of the experimental techniques taken together 
provide enough overlapping evidence to support the hypothesis that calsenilin and 
RyRs directly interact modulating RyR Ca2+ release. 
Immunostaining of neuronal tissue provided evidence that calsenilin and 
RyRs are located and co-localized in the endoplasmic reticulum of neuronal cells. To 
ensure the specificity of the primary antibodies for their target protein, all primary 
antibodies used in the experiment were tested previously and published in peer 
reviewed papers [2, 39, 112]. Localization of calsenilin and RyRs was empirically 
compared with published expression patterns to further confirm the fidelity of the 
primary antibodies used.  The algorithms used to define co-localization are sensitive 
to background fluorescence, fluorescence noise, and the relative intensity of 
immunostaining for each of the proteins.  To address the sources of artifacts two 
distinct co-localization algorithms were used. The Pearson’s coefficient is sensitive 
to relative intensities and noise, but not background fluorescence. The Mander’s 
coefficient is conversely sensitive to background fluorescence, but not relative 
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intensity of the specific protein immunostaining. By utilizing the Pearson’s and 
Mander’s coefficient, we minimized aberrations in quantification due to differences in 
the intensity of immunostaining and background staining.  To minimize artifacts from 
fluorescent noise, strict threshold values were set to delineate true fluorescent 
staining from unspecific staining.  Finally, by using the Costes algorithm, we ensured 
that co-localization was true and not due to random overlap of the fluorescent 
signals.  The resolution of a confocal microscope is well above wide field 
microscopy, but still cannot distinguish between species that are extremely close in 
proximity.  By the use of the Raleigh criterion and Nyquist sampling theorem, the 
resolution and sampling rate of the confocal microscope were optimized to ensure 
proper image acquisition.  The findings from the co-localization studies suggest that 
calsenilin and the RyRs are located in similar regions in neuronal cells.  Using a 
FRET based approach or more accurate and sophisticated imaging technology 
would increase the characterization of these two proteins interaction in vivo. 
However, to initially establish and characterize a direct protein-protein interaction the 
in vitro approach of co-immunoprecipitation was employed.   
Co-immunoprecipitation is an in vitro method for determining protein-protein 
interactions. Antibodies capture protein complexes that physically interact, and 
through immunoblotting, the proteins in this complex can be visualized. Using a 
RyR2 antibody to pulldown the RyR2 and calsenilin protein complex established a 
protein-protein interaction between calsenilin and RyR2. The antibodies used have 
been verified and published in peer reviewed papers [2, 39, 112]. The co-
immunoprecipitation experimental set up minimized artifacts due to unspecific 
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binding of the proteins to paramagnetic collection beads in three ways: 1) 
substituting the rabbit RyR2 primary antibody with rabbit IgG during incubation with a 
protein sample,  2) using a protein sample with no antibody or IgG incubation and 3) 
pre-incubation of the unlabeled paramagnetic beads with unaltered protein samples 
to allow the protein samples to bind up any non-specific sites before incubation with 
the co-immunoprecipitated antibody-protein complex.  Though all artifacts could not 
be removed in immunoblots using IgG only as the pulldown antibody, specific weight 
markers for calsenilin and RyRs showed no immunoreactivity. The use of purified 
ER microsomes harvested from several mouse brains increases the concentration of 
RyRs while lowering the concentration of superfluous proteins in the pulldown assay. 
The calsenilin content in ER microsomes is below the detection limit of 
immunoblotting, so each pulldown assay was performed with addition of 
recombinant calsenilin protein. This experimental design increases the likelihood of 
a calsenilin and RyR interaction. Though suggesting the possibility of a direct 
protein-protein interaction the presence of accessory proteins in the microsome is 
possible. Testing the functional consequence of this protein-protein interaction of 
calsenilin and RyRs was performed using single channel electrophysiology.    
 Single channel electrophysiology allows the testing of a single RyR channel 
activity.  In the current study, calsenilin altered single channel RyR Ca2+ release in a 
Ca2+ dependent manner. The several advantages to using single channel 
electrophysiology are that the native brain RyRs are used, there is absolute control 
of the experimental environment, and single channel’s biophysical properties can be 
measured.  One disadvantage of the technique is that the purified ER microsomes 
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used could contain accessory proteins still attached to the receptor.  This problem 
was addressed by using each channel as its own control therefore measuring a 
change before and after calsenilin introduction.  Electrophysiology, in general, can 
suffer from improper collection technique and a lack of proper filtering.  Both of these 
sources for error were overcome by using standard published collection rates and 
filtering techniques [67].  Finally the environment, though controlled by the 
experiment, lacks the cellular milieu of native neuronal cells. This problem is 
addressed by using optical imaging of cells overexpressing calsenilin to visualize 
Ca2+ release from RyRs in their native environment.   
 Ca2+ imaging techniques allow visualization and estimation of increased 
cytoplasmic Ca2+ levels following receptor stimulation through fluorescent Ca2+ 
binding proteins (See Figure 6).  Our studies show calsenilin overexpression in SH-
SY5Y neuroblastoma cells increases the rate of caffeine induced RyR Ca2+ release, 
decrease the duration of Ca2+ release, and increase the maximum amplitude of Ca2+ 
release from RyRs.  Using overexpression of a target protein as an in vitro model 
ensures that the interaction between two proteins occurs at a level of saturation of 
the target protein, demarcating that any changes measured in Ca2+ release 
dynamics have a high probability of being due to the protein of interest.  This 
technique suffers from inherent limitations such as cells loading differing amounts of 
Ca2+ indicator dye, photo-bleaching of the Ca2+ indicator dye, and possible 
alterations in Ca2+ release due to the transfections itself.  Using Fura-2 as the Ca2+ 
indicator dye decreased the possible aberrations from dye loading in cells and 
photobleaching.  Fura-2 is a ratiometric dye with excitation at 380nm in the unbound 
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state and 340nm in the bound state.  The emission for both is 510nm.  The use of 
the ratiometric dye addresses these anomalies due to dye loading and photo-
bleaching since absolute fluorescent values are not used.  The ratio of 340/380 is 
calculated as the output for each cell giving an accurate picture of changes within 
each individual cell bypassing any differences in dye loading and photo-bleaching.  
Previous experiments in our lab have shown the transfection technique does not 
affect Ca2+ signaling [72]. Overexpressing proteins in cells could alter several 
processes in cells. Using caffeine, a specific RyR agonist [85], ensures that Ca2+ 
release is evoked through RyRs and not another Ca2+ release channel.  Taken 
together, these results strongly suggest that calsenilin and RyRs directly interact, 
and that this interaction modifies Ca2+ release from RyRs. 
 
Calsenilin and RyRs interactions in brain signaling and disease progression 
 
Figures 7-11 show calsenilin and neuronal RyRs co-localize in the ER of 
neuronal cells.  Figure 9B clearly shows colocalization between calsenilin and RyRs 
in the major branch points of dendrites in cortical neurons.  The ER network in 
neurons spans the entire cell from the soma to the dendrites [172].  IP3Rs and RyRs 
are distributed throughout the ER in all regions of the cell [141, 149, 150, 175, 180] . 
Backpropagating action potentials are action potentials that travel from soma to axon 
and concurrently from soma through the dendritic arborization [184] . 
Backpropagating action potentials shape the responses of post synaptic cells to 
presynaptic cell stimuli , affecting the spike-timing dependence of plasticity [184].  In 
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Purkinje cells, as well as cortical and hippocampal cells, these backpropagating 
action potentials are shaped by the location of numerous ion channels including the 
RyR and IP3R [118, 158].  This alteration in spike-timing coordination between 
neurons is now thought to shape LTP and LTD in the formation of memory [10, 50, 
94, 105, 134, 138].  This study has shown there is a high density of co-localization 
between RyR and calsenilin in cortical neurons at the major dendritic branch points 
decreasing as the proximity to the soma increases (Fig 9B).  This relationship of 
RyRs expression follows a well characterized phenomenon in neurons that 
correlates to a lessening of backpropagating action potentials as the proximity to the 
soma is decreased[21, 94, 118, 149, 175].  The interaction of calsenilin with RyRs, 
as seen in the single channel electrophysiology experiments (Fig13-17), shifts the 
Ca2+ activation curve for the RyR. The shift in the Ca2+ activation curve of RyRs 
lowers single channel activity at resting, 100nM (Fig 15), Ca2+ concentrations while 
increasing single channel activity at 1µM and 10µM Ca2+ levels (Fig 16 and 17, 
respectively). The alterations in single channel Ca2+ release of RyRs translates to  
faster and higher amplitude Ca2+ release in whole cells as seen in Ca2+ imaging 
experiments (Fig 18-19).  The result of this alteration in RyR kinetics can be 
hypothesized to alter the timing and firing of a backpropagating action potentials. 
The alteration in backpropagating action potential will affect the polarization of the 
post synaptic membrane to pre synaptic signals [184].  In AD mice, the increase in 
resting concentrations of Ca2+ [102] could result in increased higher amplitude Ca2+ 
release through RyRs when modulated by calsenilin. This increase in firing rate and 
amplitude alter the pre and post synaptic firing of neurons.  In fact, this phenomenon 
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of timing in spiking potentials is a major determinant of whether LTP or LTD occurs 
[10, 50].   
 One of the major correlative features of alterations in Ca2+ signaling in AD 
mice and cellular models is the aberrant release of Ca2+ from RyRs sensitive stores 
[33, 34, 83, 152, 161, 162].  RyRs are known to form complexes with other proteins 
and channels allowing the transmission of cell signals from discrete locations [12, 
178].  In heart and skeletal muscle  RyRs form clusters of alternating receptors 
linked with L-type Ca2+ channels coordinating depolarization between cells leading 
to muscle contractions [13, 148].  The establishment of defined puncta of co-
localization of RyRs and calsenilin throughout the neuronal tissue tested here is 
reminiscent of the organization of RyRs in heart and skeletal muscle tissue [13]. This 
organization of ion channels and accessory proteins shape the propagation of waves 
throughout these excitable cells [29].  RyRs are homotetramers of four 550kDa 
subunits [61, 178].  In our co-immunoprecipitation studies, 60nM of recombinant 
calsenilin protein showed an approximately 1:1 ratio between the amounts of 
calsenilin pulled down with RyRs.  This one to one relationship between calsenilin 
and RyRs is reminiscent of the ratio of binding between calsenilin and Kv4.2 
potassium channel subunits [75, 87, 128, 181].  In this interaction, four calsenilin 
units bind to each of the four Kv4.2 potassium channel subunits in a ratio of 1:1[181].  
This interaction stabilizes the tetramer conformation and changes signaling within 
the receptor [87].  A calsenilin interaction with Kv4.2 channels changes gating 
properties of this channel, most notably by increasing the peak current, peak current 
density,  inactivation time constant, and recovery from inactivation [75].   
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In this study, a calsenilin and RyR interaction altered Ca2+ release in single 
channel electrophysiological recordings (Fig 13-17). The alteration of the Kv4.2 
channel in the presence of calsenilin allows the channel to recover more rapidly from 
inactivation allowing it to fire more frequently at higher intensities [2].  In the single 
channel electrophysiology experiments, calsenilin interaction with RyRs shifts the 
Ca2+ response curve of the RyR) to the right, (Fig 15-17), which suggests that 
activation of the RyR to Ca2+ release occurs at 1µM Ca2+ rather than 100nM Ca2+ 
(Figs. 15-16)  The silencing of the receptor at 100nM Ca2+ (Fig 15), along with the 
significant increase in channel activity at 1µM Ca2+ (Fig 16)  and 10µM Ca2+ (Fig 17) 
shows an increase density in the current transmitted per period of time through the 
receptor (Fig 14).  This change in single channel activity of RyRs can be translated 
in cells as a sharpening of RyR activity.  This effect is shown also in the Ca2+ 
imaging experiments (Fig 18-19) where Ca2+ response curves show faster and more 
robust Ca2+ release.  This data, along with the planar lipid bilayer data, suggests a 
sharpening, or tuning, of the RyR response.  Since the RyR is a CICR channel any 
alteration in the channels response to Ca2+, also alters the pattern of the Ca2+ signal 
creating an all or nothing response at specific Ca2+ concentrations.   
RyRs and IP3Rs serve multiple roles in normal physiological neuronal function 
such as propagation of action potentials, backpropagating action potentials, 
neurotransmitter release, and membrane excitability [10].  In several 
neurodegenerative disorders such as Huntington’s disease (HD), Amyotrophic 
lateral sclerosis (ALS), and AD, aberrant intracellular Ca2+  release is associated with 
cell death and disease progression [11, 15, 54, 83, 123, 160, 169].  Increased Ca2+ 
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release from intracellular stores, increased Ca2+  in response to Aβ, and increased 
Ca2+ induced apoptosis are  enhanced in AD models by overexpression of calsenilin 
[49, 78, 81, 98, 100].  The interaction between calsenilin and RyRs provides a link 
between abnormal Ca2+ signaling and these diseases.  In HD, direct interaction 
between the polyglutamine expansion of the amino terminus of the Huntington 
protein (Htt), which promotes binding to Huntington-associated protein (HAP1), is 
thought to be the cause of this disorder [170].  The interaction between this complex 
and IP3Rs elevates Ca
2+ release and apoptosis in neuronal cells [1, 169, 170].  This 
increased in IP3R Ca
2+ release can further be amplified by CICR from the RyRs [15].  
The interaction between calsenilin and RyRs enhances signaling at higher Ca2+ 
levels (Fig 16 and 17) thereby exacerbating increased IP3R Ca
2+ release.  It is 
interesting to note that increased Ca2+ release and resting Ca2+ levels in all the 
neurodegenerative disorders mentioned can be further amplified by RyRs CICR [11, 
109].  Any increase in calsenilin levels in diseases associated with abnormal Ca2+ 
could create more binding between the two species leading to increased abnormal 
Ca2+ signaling.   
 Calsenilin modulates Ca2+ homeostasis through several protein interactions 
throughout the cell.  Some of the modulators of calsenilin also modulate RyRs [144, 
155] directly linking Ca2+ signaling pathways to calsenilin.  In studies with calsenilin 
as a transcriptional modulator, interactions of calsenilin at CRE sites alter 
transcription of Ca2+ exchangers on the surface [56] increasing resting Ca2+ levels by 
limiting the extrusion of Ca2+ from the cytoplasm. It is therefore exciting to propose 
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that calsenilin may act as a modulator for competing cellular signals [144].  One 
such Ca2+ related signal is apoptosis [59]. 
Several studies have shown that increased cytoplasmic Ca2+ along with 
calsenilin overexpression can lead to apoptotic cell death [80]. Calsenilin is a 
substrate for caspase-3 cleavage [37], but it is not known if the caspase cleavage 
product of calsenilin causes apoptosis. In cell models increased apoptosis due to 
calsenilin overexpression can be normalized back to control levels with caspase 
inhibitors [36, 37, 81].  It is also interesting to note that calsenilin as a transcriptional 
modulator is responsible for the repression of pro-apoptotic transcription HRK [140], 
and is related to the transcription of anti-apoptotic proteins of the Bcl family [139].  
Calsenilin also forms a complex with the anti-apoptotic N-terminus of PS2 further 
suggesting a role as a signaling molecule in apoptosis [24].   
 
Structural basis for interaction between calsenilin and RyRs 
 
Calsenilin interacts with Kv4.2 channels modulating channel activity [76].  The 
binding calsenilin forms a tetrameric structure stabilizing the four Kv4.2 channel 
subunits [87].  The scaffolding protein Homer mediates the interaction between 
RyRs and Cav1.2 (L-type voltage gated Ca2+ channels) in cardiac cells. This 
interaction regulates Ca2+ microdomains by coupling L-type VOCC calcium entry 
with RyR release [71]. Therefor L-type-calcium activation directly modulates the 
release of Ca2+ from RyR [188].  Homer proteins form tetrameric structures [64] 
stabilizing post synaptic densities [65] in neurons. The tetramerization of Homer 
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proteins into a scaffolding structure is through interactions in leucine zipper domains 
of the Homer proteins [167].  Calsenilin interacts with αCREM at the kinase inducible 
domain (KID) of the leucine zipper in αCREM [95]. This interaction occurs between 
the two leucine charge residue rich domains (LCD) located in both calsenilin and 
αCREM [92]. These findings suggest that calsenilin and Homer may interact through 
motifs located in the leucine zipper domain of Homer.  Recently, calsenilin has been 
shown to play a role in the interaction between Kv4.2 channels and Cav3 (M-type 
voltage gated Ca2+ channels) linking Ca2+ release through M-type voltage gated 
Ca2+ channels with modulation of Kv4.2 channels by calsenilin [3]. Calsenilin interacts 
with Kv4.2 channels around the pore forming segment of Kv4.2 channels [18].  
Interestingly, the pore regions of RyRs and A-type potassium channels share 
structural features. Crystal structures of the pore region for both channels were 
elucidated using the same bacterial K1 channel KcsA as a template [18, 187].  As 
seen in co-immunoprecipitation studies, the addition of 60nM calsenilin to ER 
microsomes showed expression of calsenilin: RyR in a 1:1 ratio.  This same type of 
ratio of calsenilin: Kv4.2 is described in the formation of calsenilin and Kv4.2 channel 
complexes and is needed for the alterations in channel release seen in this structure 
[7, 181].  
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Future directions 
 
As higher resolution imaging technology becomes available, the nanodomain 
interaction between calsenilin and RyRs can be viewed. The higher resolution 
imaging would allow a more precise analysis of the exact localization of these two 
proteins in vivo.  Colocalization in distal dendrites and the density of this 
colocalization, with respect to the proximity to the soma, would provide evidence for 
the functional consequence of this protein-protein interaction in neuronal 
communication. In hippocampal neurons, RyRs are located in the most distal 
branches of dendrites and responsible for the propagation of Ca2+ signals 
throughout the dendritic tree [150, 180]. Whether calsenilin modulation effects the 
propagation of Ca2+ signals through dendritic branches has yet to be determined.  A 
more specific survey of calsenilin and RyR colocalization in neural pathways would 
provide evidence for an exact physiological role of calsenilin and RyR interaction.  
Determination of the Ca2+ dependence of the calsenilin and RyR interaction would 
shed more light on the mechanism of RyR modulation.  Mutations in each of the 
Ca2+ binding EF –hand domains of calsenilin would provide an in vitro method to 
determine the importance of specific Ca2+ binding sites on the interaction and 
modulation of RyRs.  
 Calsenilin EF-hand mutations that disrupt Ca2+ binding result in loss of 
function in transcription modulation and potassium channel modulation by calsenilin.  
During transcriptional regulation, mutations preventing the binding of Ca2+ to all 4 –
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EF-hands of calsenilin result in calsenilin being irreversibly bound to the DRE site 
[121]. Calsenilin interaction with Kv4.2 channels is not abolished when mutations 
prevent Ca2+ binding to all 4 –EF-hands of calsenilin, but the modulatory effect of the 
interaction is removed [182]. Calsenilin has 4-EF hands with different binding 
affinities for Ca2+ [120], the importance of each of these binding sites on the function 
of calsenilin has yet to be resolved.  Using single channel electrophysiology, single 
EF-hand mutations that prevent Ca2+ binding to calsenilin, and their effect on the 
modulation of RyRs channel activity would be measured.   
 The whole cell paradigm in this study could be improved by a more 
quantitative measure of overexpression of calsenilin to identify if the changes in Ca2+ 
signaling are sensitive to the concentration of calsenilin.  In in vitro studies it has 
been shown that the concentration of calsenilin effects the formation of dimers and 
tetramers [120, 121], these interactions of calsenilin confer the action of calsenilin in 
transcriptional regulation as well as Kv4.2 channel modification[75, 121] 
In our current study, we have established that calsenilin and RyRs interact 
through a direct protein-protein interaction.  It would be interesting to further 
elucidate properties of this interaction by testing the Ca2+ dependence on this 
interaction as stated earlier.  It would also be interesting to establish whether the 
caspase cleavage product of calsenilin binds with the RyR, as well as understanding 
how phosphorylation of RyRs and calsenilin effect this interaction.  Further 
experiments in hippocampal neurons with specific emphasis on pre and post 
synaptic connections with calsenilin and RyRs would allow a more precise definition 
of what this interaction means for synaptic signaling.   
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The interaction between calsenilin and RyRs could provide a specific 
pharmacological site for the modulation of intracellular Ca2+ in neurons.  The Taiwan 
banded krait beta-bungarotoxin specifically and irreversibly binds calsenilin, but 
none of the other isoforms in the calsenilin NCS family [101].  Hadrucalcin, a peptide 
from Hadrurus gertschi scorpion venom, specifically and irreversibly interacts with 
RyRs [145].  The discovery of the binding sites of these compounds on calsenilin 
and RyR could lead to the production of a compound that targets the interaction 
between these two proteins.  By creating a genetic dimer of the toxins the compound 
could bind both calsenilin and RyRs covalently.  The consequence of this interaction 
could be tested easily in whole cell assays and single channel electrophysiology.  
To conclude, we have provided evidence for a calsenilin interaction with 
neuronal RyRs. The interaction has a biophysical effect on single channel RyRs, as 
well as a modulatory effect on a population of RyRs in a whole cell paradigm.  These 
are important findings in that could aid future investigations into the dysfunction of 
calsenilin regulation in neurodegenerative diseases such as AD, and potentially be a 
target for therapeutic intervention.   
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